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ABSTRACT 
 
A Lewis acid catalyzed Friedel-Crafts reaction between donor-acceptor aminocyclopropanes and indoles and other 
electron-rich aromatic compounds is reported. Indole alkylation at the C3 position was generally obtained for a broad 
range of functional groups and substitution patterns. In the case of C3-substituted indoles, C2 alkylation was 
observed. The reaction gives a rapid access to gamma amino acid derivatives present in numerous bioactive 
molecules.  
Substituted γ-aminobutyric acid (GABA) derivatives 
are found in numerous natural and synthetic 
neurotransmitters,1 in peptidomimetics2 and in the core of 
a large number of alkaloid natural products. In particular, 
electron-rich aromatic substituents are frequently 
encountered in the γ position of GABA derivatives in 
important classes of natural products, such as the indole 
alkaloids vindoline (1) and eburnamonine (2) or the 
Erythrina alkaloid 3-demethoxyerythratidinone (3) 
(Scheme 1). Consequently, a fast and general approach to 
these key building blocks would be highly desirable.3 
In this context, the nucleophilic attack of an electron-
rich aromatic or an amine at the  position of a carbonyl 
group would give an efficient entry into this important 
class of GABA derivatives (Scheme 1). In order to 
achieve this transformation, the Umpolung of the normal 
reactivity at the nucleophilic position is required. 
                                                     
(1) (a) Johnston, G. A. R. Pharm.Ther. 1996, 69, 173. (b) Chebib, 
M.; Johnston, G. A. R. J. Med. Chem. 2000, 43, 1427.  
(2) Sudev, P. G.; Chatterjee, S.; Shamala, N.; Balaram, P. Chem. Rev. 
2011, 111, 657. 
(3) Ordóñez, M.; Cativiela, C. Tetrahedron: Asymmetry 2007, 18, 3. 
Activated donor-acceptor (DA) cyclopropanes represent 
such Umpolung synthons and have been used in the past 
as olefin homologs.4 In previous studies the nucleophilic 
attack of an amine onto aromatic DA cyclopropanes has 
been reported to access GABA analogs (Scheme 1, (1)).5 
If a high diversity in the aromatic substituent is desired, 
an alternative approach involving attack of a nucleophilic 
aromatic compound onto a nitrogen-substituted synthon 
as represented by an aminocyclopropane would be more 
efficient (Scheme 1, (2)). Nevertheless, such an approach 
has not yet been exploited. 
                                                     
(4) (a) Reissig, H.-U.; Zimmer, R. Chem. Rev. 2003, 103, 1151. (b) 
Yu, M.; Pagenkopf, B. L. Tetrahedron 2005, 61, 321. (c) Rubin, M.; 
Rubina, M.; Gevorgyan, V. Chem. Rev 2007, 107, 3117. (d) De Simone, 
F.; Waser, J. Synthesis 2009, 2009, 3353. (e) Carson, C. A.; Kerr, M. A. 
Chem. Soc. Rev. 2009, 38, 3051. Theoretical study: (f) Schneider, T. F.; 
Werz, D. B. Org. Lett. 2011, 13, 1848. 
(5) (a) Blanchard, L. A.; Schneider, J. A. J. Org. Chem. 1986, 51, 
1372-1374. (b) Lifchits, O.; Charette, A. B. Org. Lett. 2008, 10, 2809. 
(c) Lindsay, V. N. G.; Nicolas, C.; Charette, A. B. J. Am. Chem. Soc. 
2011, 133, 8972. (d) So, S. S.; Auvil, T. J.; Garza, V. J.; Mattson, A. E. 
Org. Lett. 2012, 14, 444. (e) Zhou, Y. Y.; Wang, L. J.; Li, J.; Sun, X. L.; 
Tang, Y. J. Am. Chem. Soc. 2012, 134, 9066. (f) Emmett, M. R.; Grover, 
H. K.; Kerr, M. A. J. Org. Chem. 2012, 77, 6634. 
On the other hand, intermolecular Friedel-Crafts 
reactions between donor-acceptor cyclopropanes and 
electron-rich aromatic compounds including indoles have 
been studied in the past, especially by the groups of Kerr, 
Pagenkopf and Ivanova.6 In 2013, Johnson developed an 
enantioselective Friedel-Crafts reaction between aryl 
cyclopropane and silyl-protected indoles using a chiral 
Lewis acid catalyst.7 However, only alkyl, aryl or alkoxy 
substituents have been used as the donating group on the 
cyclopropane.8 
 
Scheme 1. Natural products containing a GABA-derived core 
and key disconnections. 
 
 
Since 2010, our group has been involved in the study 
of the reactivity of aminocyclopropanes.9 The release of 
ring strain combined with bond polarization allowed the 
generation of reactive  a 1,3 zwitterionic synthon, which 
could cyclize on indoles or react with enol ethers, 
aldehydes and ketones to afford cyclopentyl- and 
tetrahydrofuryl- amines. In this latter work, optimization 
of the electronic properties of the substituents on the 
nitrogen resulted in the discovery that phthalimide-
substituted cyclopropane diesters afford the right balance 
between reactivity and stability.9c-e Herein, we would like 
                                                     
(6) (a) Harrington, P.; Kerr, M. A. Tetrahedron Lett. 1997, 38, 5949. 
(b) Kerr, M. A.; Keddy, R. G. Tetrahedron Lett. 1999, 40, 5671. (c) 
England, D. B.; Woo, T. K.; Kerr, M. A. Can. J. Chem. 2002, 80, 992. 
(d) Grover, H. K.; Lebold, T. P.; Kerr, M. A. Org. Lett. 2011, 13, 220. 
(e) Emmett, M. R.; Kerr, M. A. Org. Lett. 2011, 13, 4180. (f) Bajtos, B.; 
Yu, M.; Zhao, H. D.; Pagenkopf, B. L. J. Am. Chem. Soc. 2007, 129, 
9631. (g) Ivanova, O. A.; Budynina, E. M.; Grishin, Y. K.; Trushkov, I. 
V.; Verteletskii, P. V. Eur. J. Org. Chem. 2008, 5329 (h) Chagarovskiy, 
A. O.; Budynina, E. M.; Ivanova, O. A.; Grishin, Y. K.; Trushkov, I. V.; 
Verteletskii, P. V. Tetrahedron 2009, 65, 5385. 
(7) Wales, S. M.; Walker, M. M.; Johnson, J. S. Org. Lett. 2013, 15, 
2558.  
(8) There is a single example of aminocyclopropanes opening by 
trimethoxybenzene: Gharpure, S. J.; Vijayasree, U.; Reddy, S. R. B. 
Org. Biomol. Chem. 2012, 10, 1735. During their recent work on the 
Friedel-Crafts alkylation of indoles,7 Johnson and co-workers studied 
the use of phthalimido-cyclopropanes, but no reactivity was observed 
under their conditions. 
(9) (a) De Simone, F.; Gertsch, J.; Waser, J. Angew. Chem., Int. Ed. 
2010, 49, 5767. (b) De Simone, F.; Saget, T.; Benfatti, F.; Almeida, S.; 
Waser, J. Chem. Eur. J. 2011, 17, 14527. (c) de Nanteuil, F.; Waser, J. 
Angew. Chem., Int. Ed. 2011, 50, 12075. (d) Benfatti, F.; de Nanteuil, 
F.; Waser, J. Org. Lett. 2012, 14, 386. (e) Benfatti, F.; de Nanteuil, F.; 
Waser, J. Chem. Eur. J. 2012, 18, 4844. 
to report the first successful intermolecular Friedel-Crafts 
reaction of indoles with aminocyclopropanes based on 
fine-tuning of the electron-withdrawing properties of the 
diester group and the identification of scandium triflate as 
the best catalyst (Scheme 2). The reaction worked with 
unprotected indoles as well as other electron-rich 
aromatic compounds and tolerated a broad range of 
functional groups. In the case of C3-substituted indoles, 
C2-alkylated products could be obtained, probably via a 
selective 1,2-shift of the amino acid side-chain. 
 
Scheme 2. Friedel-Crafts with diester aminocyclopropane 4a 
 
 
Preliminary screening of Lewis acids and solvents 
allowed us to identify scandium triflate in nitromethane as 
promising conditions for the alkylation of N-protected 
indoles with the phthaloyl protected aminocyclopropane 
diester 4b at room temperature.10 However, when 
switching to unprotected indole (5a), double addition 
product 7a was observed as major side product in the 
reaction mixture (Scheme 3). Even after extensive 
optimization of the reaction conditions, it was not 
possible to achieve full selectivity toward the desired 
product 6.  
 
Scheme 3. Fine-tuning of the aminocyclopropane structure for 
the Friedel-Crafts alkylation of indole (5a). 
 
Reaction conditions: cyclopropane (0.034 mmol), 5a (0.051 mmol), 
Sc(OTf)3 (3.4 µmol), nitromethane (0.2 mL), rt, 1 h. 
aDetermined by 1H 
NMR of the crude reaction mixture. bDCM (0.5 mL) was used. cThe bis-
indole adduct 7b was not isolated. The NMR ratio was determined by 
analogy with 7a. 
 
                                                     
(10) See Supporting Information for a complete list of tested reaction 
conditions and Lewis acids. 
We then turned our attention to the further adjustment 
of the structure of the aminocyclopropane. A series of 
aminocyclopropanes 4c-f with different nitrogen 
protecting groups were examined in the alkylation 
reaction. The use of electron-poor bromo and dichloro 
derivatives 4c and 4d of phthalimide as well as a smaller 
maleimide 4e or a larger naphthylimide 4f on the 
cyclopropane did not have a favorable impact on the 
selectivity. In contrast, modification of the acceptor 
diester group (cyclopropanes 4g and 4a) had a strong 
influence on the reaction outcome. The best selectivity 
was obtained using the more electron-withdrawing 
trifluoro ethanol derivative 4a, which afforded only the 
desired product. Finally, replacing the toxic nitromethane 
by diethyl ether was possible without loss of selectivity.  
With this simple protocol for the addition of indole to 
aminocyclopropanes in hand, we investigated the scope of 
the reaction (Table 1). As showed during optimization, 
unprotected indole (5a) was a suitable partner for the 
reaction and the product 6aa could be isolated in 85 % 
yield on a 0.2 mmol scale and in 87 % yield on a 2.8 
mmol scale, showing that scaling up was straightforward 
for this transformation (entry 1). Electron-donating 
(methoxy) and -withdrawing (chloro, bromo and nitro) 
substituents on the benzene ring were well tolerated 
(entries 2-6). The compatibility with halogens or a 
boronic ester is particularly interesting, as the obtained 
products are easily further functionalized via cross-
coupling reactions. Next, the use of N-alkyl substituted 
indoles was investigated (entries 7-9). N-methyl indole 
(5g) afforded the alkylation product 6ag in 94 % yield on 
a 0.2 mmol scale and in 83 % yield on a 2.4 mmol scale 
(entry 7). A protected alcohol on the N-alkyl chain (entry 
8) as well as an ester group on the benzene ring (entry 9) 
were well tolerated. Alkylation of indoles substituted at 
the position C2 by an alkyl, an aryl or a more sensitive 
alkynyl11 functionality was also possible in 52-97% yield 
(entries 10-12). When C3-substituted indoles were 
examined as substrates, selective C2-alkylation was 
observed (entries 13-15). This product is probably formed 
by C3-alkylation, followed by 1,2-alkyl shift.6c,12 This 
result is interesting, as in most reactions of C3-substituted 
indoles with cyclopropanes, a [3+2] annulation occurs 
preferentially over 1,2-shift.6b,13 The observed outcome 
could be due to the ability of the nitrogen substituent to 
stabilize a partial positive charge during the alkyl shift.  
 
 
 
                                                     
(11) Obtained in one step by the alkynylation of N-methyl indole (5g) 
using a method developed in our group: Tolnai, G. L.; Ganss, S.; Brand, 
J. P.; Waser, J. Org. Lett. 2013, 15, 112. 
(12) Alternative mechanisms involving direct addition on the C2 
position or reversible C3-addition in competition with irreversible C2 
addition cannot be completely excluded, but appeared less probable: The 
former due to the higher electron-density at the C3 position, and the 
latter as it would require the formation of an highly reactive 
carbocationic intermediate or a strained cyclopropane. 
(13) Xiong, H.; Xu, H.; Liao, S.; Xie, Z.; Tang, Y. J. Am. Chem. Soc. 
2013, 135, 7851. 
 
Table 1. Friedel-Crafts reaction with aminocyclopropane 4a. 
 
entry indole product yield(%)a 
 
 
 
 
1 R = H (5a) 6aa 85 (87)b 
2 R = Cl (5b) 6ab 82 
3 R = OMe (5c) 6ac 68 
4 R = Bpin (5d) 6ad 63 
5 
  
70 
6 
 
 
58c 
7 
 
 
94 (83%)d 
8 
 
 
80 
9 
 
 
86 
10 
  
97 
11 
  
93 
12 
 
 
52 
13 
  
82e 
14 
  
49f 
15 
  
72c,f 
E = CO2CH2CF3. Reaction conditions: 4a (0.20 mmol), indole (0.22 
mmol), Sc(OTf)3 (0.01 mmol), Et2O (1.2 mL), rt. 
aIsolated yields. bOn a 
1.5 g scale. cIsolated after transesterification (see Supporting 
Information for more details). dOn a 1.3 g scale. eReaction in Et2O at 35 
°C. fReaction in toluene at 60 °C.  
 
The C2 alkylation was not limited to skatole (entry 13), 
but the reaction was slower for other substrates and 
heating to 60 °C was required to obtain full conversion in 
the case of 3-alkynyl indole 5n14 (entry 14) and protected 
tryptophol 5o (entry 15). For the latter, protection of the 
oxygen was required to prevent side reactions.  
Finally, we wondered if this protocol could be 
extended to other classes of electron-rich aromatic 
compounds (Figure 1). Although furans and thiophenes 
were unreactive under these conditions, pyrrole reacted 
efficiently to give a 2:1 C2/C3 mixture of regioisomers 8a 
and 8b in 91% yield.15 Protection of the nitrogen of 
pyrrole with a triisopropylsilyl group allowed to switch 
the selectivity and to isolate the C3-alkylated product 9b 
with good selectivity. Anisole could also be used, leading 
to a mixture of para/ortho alkylation products 10a and 
10b. In the case of phenol, product 11b resulting from O 
alkylation was the major product. These preliminary 
results highlight the broad potential of donor-acceptor 
substituted aminocyclopropanes for the Friedel-Crafts 
alkylation of electron-rich aromatic compounds. 
 
Figure 1. Products of the alkylation of electron-rich aromatic 
compounds. 
 
aReaction conditions: 4a (0.20 mmol), aromatic compound (0.22 
mmol), Sc(OTf)3 (0.01 mmol), Et2O (1.2 mL), rt.; Isolated yield. 
bRatio 
of isolated material. cDetermined by 1H NMR.  
 
In order to show that the products are useful synthetic 
precursors, deprotection of the phthalimide was 
conducted using diaminoethane in isopropanol after 
transesterification of the difluoroethanol malonate 
(Scheme 4, (1)). During this process, the free amine 
cyclized on the malonic ester giving lactam 12a and 12b 
as a 1:1 ratio of equilibrating diastereoisomers. An 
efficient access to substituted  lactams is interesting, as 
they represent an important class of bioactive natural 
products and synthetic drugs. Modified Krapcho 
conditions16 allowed us to obtain the mono-ester 
derivative 13 in quantitative yield (Scheme 4, (2)). When 
                                                     
(14) Obtained in one step by the alkynylation of indole (5a) using a 
method developed in our group: Brand, J. P.; Charpentier, J.; Waser, J. 
Angew. Chem., Int. Ed. 2009, 48, 9346. 
(15) These results are in accordance with the lower nucleophilicity of 
furans and thiophenes as quantified by Mayr’s reactivity scale: Mayr, 
H.; Ofial, A. R. J. Phys. Org. Chem. 2008, 21, 584. 
(16) Kaburagi, Y.; Tokuyama, H.; Fukuyama, T. J. Am. Chem. Soc. 
2004, 126, 10246. 
these conditions were applied to C2 adduct 6am, tricyclic 
product 14, which correspond to the core skeleton of 
natural products such as eburnamonine (2), was isolated 
in 73 % yield (Scheme 4, (3)). 
 
Scheme 4. Synthetic transformations of the alkylation products. 
 
 
In conclusion, we have shown that phthaloyl protected 
diester aminocyclopropanes are powerful homo-olefin 
equivalents in Friedel-Crafts alkylation reactions and 
readily react with electron-rich aromatic compounds to 
afford GABA analogues. C2-alkylation was observed for 
C3-substitued indoles, which is probably the result of C3-
alkylation followed by selective shift of the amino-
substituted alkyl chain. Finally, the synthetic potential of 
the products was highlighted by the easy removal of the 
phthaloyl protecting group, as well as Krapcho 
decarboxylation. Future works will focus on the 
development of enantioselective methods, as well as the 
application of this transformation in the synthesis of 
bioactive natural products. 
Supporting Information. Experimental procedures 
and analytical data for all new compounds. This material 
is available free of charge via the Internet at 
http://pubs.acs.org. 
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1. General Methods 
 
All reactions were carried out in oven-dried glassware under an atmosphere of nitrogen, unless stated otherwise. 
For quantitative flash chromatography, technical grade solvents were used. For flash chromatography for 
analysis, HPLC grade solvents from Sigma-Aldrich were used. Tetrahydrofuran, Diethyl ether, toluene, hexane 
and CH2Cl2 were dried by passage over activated alumina under nitrogen atmosphere (H2O content < 7 ppm, 
Karl-Fischer titration). All chemicals were purchased from Acros, Aldrich, Fluka, VWR, Aplichem or Merck 
and used as such. Chromatographic purification was performed as flash chromatography using Macherey-Nagel 
silica 40-63, 60 Å, using the solvents indicated as eluent with 0.1-0.5 bar pressure. TLC was performed on 
Merck silica gel 60 F254 TLC plastic plates and visualized with UV light, CAN stain or p-anisaldehyde stain. 
Melting points were measured on a calibrated Büchi B-540 melting point apparatus using open glass capillaries. 
1H-NMR spectra were recorded on a Brucker DPX-400 400 MHz spectrometer in chloroform-d, all signals are 
reported in ppm with the internal chloroform signal at 7.26 ppm as standard. The data is being reported as (s = 
singlet, d = doublet, t = triplet, q = quadruplet, qi = quintet, m = multiplet or unresolved, br = broad signal, 
integration, coupling constant(s) in Hz, interpretation). 13C-NMR spectra were recorded with 1H-decoupling on a 
Brucker DPX-400 100 MHz spectrometer in chloroform-d, all signals are reported in ppm with the internal 
chloroform signal at 77.16 ppm as standard. Infrared spectra were recorded on a JASCO FT-IR B4100 
spectrophotometer with an ATR PRO410-S and a ZnSe prism and are reported as cm-1 (w = weak, m = medium, 
s = strong). High resolution mass spectrometric measurements were performed by the mass spectrometry service 
of ISIC at the EPFL on a MICROMASS (ESI) Q-TOF Ultima API. HPLC measurement were done on a JASCO 
HPLC system with an AS2055 Autosampler, a PU 2089 Pump, a UV 2075 detector and a SEDEX 85 (SEDERE) 
detector using a CHIRALPAK IC, IB or IA column from DAICEL Chemical Industries Ltd. HPLC grade 
solvents from Sigma-Aldrich were used. Scandium triflate was stored and weighted in a glovebox. 
Commercially available N-Vinyl Phthalimide [3485-84-5], p-Acetamidobenzenesulfonyl Azide [2158-14-7] 
were used 
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2. Synthesis of diazo compounds 
 
Bis(2,2,2-trifluoroethyl) malonate (17) 
 
 
 
Following a reported procedure,1 a 250 mL round-bottom flask equipped with a condenser was charged with 
malonic acid (16) (8.00 g, 77.0 mmol, 1 equiv), 2,2,2-trifluoroethanol (15) (29.6 mL, 412 mmol, 5.4 equiv), 
benzene (40.0 mL) and sulfuric acid (1.00 mL, 19.0 mmol, 0.25 equiv). The flask was flushed with nitrogen and 
the reaction mixture refluxed overnight under nitrogen atmosphere. Afterwards, the reaction mixture was 
allowed to cool to room temperature, diluted with additional benzene (80 mL), and washed sequentially with 
10% sodium carbonate (3 x 80 mL), water (80 mL), and brine (80 mL). The organic layer was dried over 
anhydrous sodium sulfate and concentrated under reduced pressure to afford bis(2,2,2-trifluoroethyl) malonate 
(17) (7.19 g, 26.8 mmol, 35%) as a colorless oil. 
 
1H NMR (400 MHz, CDCl3) δ 4.54 (q, 4 H, J = 8.3 Hz, CH2-CF3), 3.60 (s, 2 H, CH2-(CO)2);  
13C NMR (101 MHz, CDCl3) δ 164.1, 122.5 (q, JC-F = 277 Hz), 61.1 (q, JC-F = 37 Hz), 40.0;  
19F NMR (376 MHz, CDCl3) δ -74.11 (t, J = 8.3 Hz);  
 
The characterization data correspond to the reported values.1 
 
Bis(2,2,2-trifluoroethyl) 2-diazomalonate (19) 
 
 
 
Bis(2,2,2-trifluoroethyl) malonate (17) (5.00 g, 18.7 mmol, 1 equiv), triethylamine (2.84 mL, 20.5 mmol, 1.1 
equiv) and 4-acetamidobenzenesulfonyl azide (18) (4.93 g, 20.5 mmol, 1.1 equiv) were dissolved in acetonitrile 
(180 mL) at room temperature. After stirring the resulting mixture overnight, the suspension was filtered through 
a plug of cotton wool and the solvent was removed under reduced pressure. The crude was dissolved in 
dichloromethane (200 mL), filtered through a plug of cotton wool, and partitioned between dichloromethane and 
water (200 mL). The two layers were separated and the aqueous layer was extracted with dichloromethane (2 x 
150 mL). The combined organic layers were dried over MgSO4, concentrated under reduced pressure and dried 
under vacuum. Filtration through a plug of silica (AcOEt/hexane 1/1 + 1% NEt3, 500 mL) afforded bis(2,2,2-
trifluoroethyl) 2-diazomalonate (19) (5.44 g, 18.5 mmol, 99% yield) as a yellow oil  which was not further 
purified. 
 
Rf 0.67 (hexane/ethyl acetate 6/4);  
1H NMR (400 MHz, CDCl3) δ 4.62 (q, 4 H, J = 8.2 Hz, CH2);  
13C NMR (101 MHz, CDCl3) δ 158.7, 122.6 (q, JC-F = 277 Hz), 60.9 (q, JC-F = 37 Hz)2;  
IR 2985 (w), 2154 (m), 1777 (s), 1715 (m), 1417 (m), 1357 (m), 1280 (s), 1168 (s), 1102 (s);  
HRMS (ESI) calcd for C7H4F6N2NaO4+ [M+Na]+ 316.9967; found 316.9972. 
 
Dimethyl 2-diazomalonate (21) 
 
 
 
Dimethyl malonate (20) (3.20 g, 24.2 mmol, 1 equiv), triethylamine (5.00 mL, 36.1 mmol, 1.5 equiv) and 4-
acetamidobenzenesulfonyl azide (18) (6.00 g, 25.0 mmol, 1 equiv) were dissolved in acetonitrile (65.0 mL) at 
                                                          
1 J. M. Takacs, Z. Xu, X.-T. Jiang, A. P. Leonov, G. C. Theriot, Org. Lett. 2002, 4, 3843. 
2 The diazo carbon could not be detected. 
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room temperature. After stirring the resulting mixture overnight, the suspension was filtered through a plug of 
cotton wool and the solvent was removed under reduced pressure. The crude was partitioned between 
dichloromethane (75 mL) and water (75 mL) and filtered through a plug of cotton wool. The two layers were 
separated and the aqueous layer was extracted with dichloromethane (75 mL). The combined organic layers were 
dried over MgSO4 and concentrated under reduced pressure. Filtration over a plug of silica (ethyl acetate/hexane 
1/1, 150 mL)) afforded dimethyl 2-diazomalonate (21) (3.60 g, 22.8 mmol, 94% yield) as pale yellow crystals. 
Rf 0.32 (PET/Diethyl ether 1/1);  
1H NMR (400 MHz, CDCl3) δ 3.87 (s, 1 H, OCH3);  
13C NMR (101 MHz, CDCl3) δ 161.2, 52.4.3 
 
The 1H NMR correspond to the reported values.4 
 
Dibenzyl 2-diazomalonate (23) 
 
 
 
Dibenzyl malonate (22) (2.00 g, 7.03 mmol, 1 equiv), triethylamine (1.10 mL, 7.70 mmol, 1.1 equiv) and 4-
acetamidobenzenesulfonyl azide (18) (1.81 g, 7.53 mmol, 1.1 equiv) were dissolved in acetonitrile (70.0 mL) at 
room temperature. After stirring the resulting mixture overnight, the suspension was filtered through a plug of 
cotton wool and the solvent was removed under reduced pressure. The crude was partitioned between 
dichloromethane (100 mL) and water (100 mL), and filtered through a plug of cotton wool. The two layers were 
separated and the aqueous layer was extracted with dichloromethane (100 mL). The combined organic layers 
were dried over MgSO4, concentrated under reduced pressure and dried under vacuum. Filtration over a plug of 
silica (Diethyl ether/hexane 1/1, 150 mL) afforded dibenzyl 2-diazomalonate (23) (2.03 g, 6.53 mmol, 93% 
yield) as a yellow solid. 
 
Rf 0.69 (6/4 Hexane/AcOEt);  
Mp 48.2 – 51.1 °C;  
1H NMR (400 MHz, CDCl3) δ 7.38-7.32 (m, 10 H, Ar), 5.28 (s, 4 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 160.9, 135.4, 128.8, 128.6, 128.4, 67.2, 41.7;  
IR 3064 (w), 3035 (w), 2950 (w), 2888 (w), 2140 (s), 1756 (s), 1732 (s), 1692 (m), 1456 (w), 1385 (m), 1315 
(s), 1268 (m), 1087 (s).  
HRMS (ESI) calcd for C17H15N2O4+ [M+H]+ 311.1026; found 311.1016. 
 
  
                                                          
3 The diazo carbon could not be detected. 
4 P. Wyatt, A. Hudson, J. Charmant, A. G. Orpen, H. Phetmung, Org. Biomol. Chem. 2006, 4, 2218. 
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3. Synthesis of Aminocyclopropanes 
 
Bis(2,2,2-trifluoroethyl) 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (4a) 
 
 
 
Following a modified procedure,5 a solution of bis(2,2,2-trifluoroethyl) 2-diazomalonate (19) (1.0 g, 3.4 mmol, 
1.1 equiv) in dichloromethane (4.0 mL) was added dropwise over 5 minutes to a solution of 2-vinylisoindoline-
1,3-dione (24) (540 mg, 3.1 mmol, 1 equiv) and bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] 
(4.7 mg, 6.2 µmol, 0.2 mol %) in dichloromethane (6.0 mL) at 0 °C. After stirring the resulting mixture 
overnight at room temperature, the solution was concentrated under reduced pressure. Purification by silica gel 
chromatography (hexane/AcOEt 95/5 to 75/25) afforded bis(2,2,2-trifluoroethyl) 2-(1,3-dioxoisoindolin-2-
yl)cyclopropane-1,1-dicarboxylate (4a) (1.3 g, 3.0 mmol, 97% yield) as a colorless solid. 
 
Rf 0.61 (hexane/ethyl acetate 6/4);  
Mp 76.3 – 78.0 °C;  
1H NMR (400 MHz, CDCl3) δ 7.87-7.82 (m, 2 H, Phth), 7.77-7.72 (m, 2 H, Phth), 4.61 (q, 2 H, J = 8.2 Hz, CH2-
CF3), 4.50-4.30 (m, 2 H, CH2-CF3), 3.83 (dd, 1 H, J = 8.6, 6.9 Hz, CH-Phth), 2.90 (dd, 1 H, J = 6.8, 6.8 Hz, 
CH2), 2.19 (dd, 1 H, J = 8.6, 6.6 Hz, CH2);  
13C NMR (101 MHz, CDCl3) δ 167.7, 166.4, 164.5, 134.7, 131.4, 123.8, 122.7 (q, JC-F = 277 Hz), 122.5 (q, JC-F 
= 277 Hz), 61.7 (q, JC-F = 37 Hz), 61.5 (q, JC-F = 37 Hz), 36.4, 32.7, 21.0;  
IR 3495 (w), 3121 (w), 3037 (w), 2981 (w), 1724 (s), 1397 (m), 1277 (s), 1163 (s), 1116 (s), 975 (m);  
HRMS (ESI) calcd for C17F6H12NO6+ [M+H]+ 440.0563; found 440.0555. 
 
Dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (4b) : 
 
 
 
Following a modified procedure,5 bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] (11 mg, 
0.014 mmol, 0.1 mol%) is weighted in the glovebox. The flask is closed with a septum and put under N2 
atmosphere. A solution of N-vinyl-phthalimide (24) (2.5 g, 14 mmol, 1 equiv) in 30 mL of dry dichloromethane 
is added and the resulting green suspension is cooled down to 0°C with an ice/water bath. A solution of 
dimethyl-2-diazomalonate (21) (2.5 g, 15 mmol, 1.1 equiv) in dichloromethane (20 mL) is added over five 
minutes. When the addition is complete, the reaction is allowed to warm to room temperature. After 5 h at room 
temperature, the solvent is removed under reduced pressure and the crude is directly purified by column 
chromatography (9:1 Hexane/Ethyl Acetate to 7:3 Hexane/Ethyl Acetate) to afford 4b (3.4 g, 11 mmol, 78% 
yield) as a colorless solid.  
 
Rf 0.27 (6:4, Hexane/Ethyl acetate); 
Mp 124.6-125 °C; 
1H NMR (400 MHz, CDCl3) δ 7.86 (m, 2 H, Phth), 7.75 (m, 2 H, Phth), 3.85 (s, 3 H, OMe), 3.72 (dd, 1 H, J = 
8.5, 6.6 Hz, N-CH), 3.64 (s, 3 H, OMe), 2.73 (dd, 1 H, J = 6.5, 6.5 Hz, CH2), 2.06 (dd, 1 H, J = 8.5, 6.4 Hz, 
CH2);  
13C NMR (101 MHz, CDCl3) δ 168.5, 167.8, 166.9, 134.3, 131.4, 123.5, 53.1, 53.0, 34.9, 33.1, 19.6;  
IR 2956 (w), 1783 (w), 1727 (s), 1468 (w), 1439 (w), 1399 (m), 1329 (m), 1294 (m), 1222 (m), 1134 (w), 909 
(w), 876 (w), 720 (m); 
HRMS (ESI) calcd for C15H14NO6+ [M+H]+ 304.0816; found 304.0804. 
                                                          
5 F. Gonzalez-Bobes, M. D. B. Fenster, S. Kiau, L. Kolla, S. Kolotuchin, M. Soumeillant, Adv. Synth. Catal. 
2008, 350, 813. 
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The characterization data correspond to the reported values.6  
 
Dimethyl 2-(5-bromo-1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (4c) 
 
 
 
Following a modified procedure7, 5-bromoisobenzofuran-1,3-dione (25) (500 mg, 2.20 mmol, 1 equiv) and 
formamide (26) (8.82 mL, 220 mmol, 100 equiv) were added in a 20 mL microwave vial and sealed with a 
microwave cap. The mixture was stirred until the product was completely dissolved. The mixture was heated 
twice at 200 °C for 30 sec with 10 sec pre-stirring, using Biotage Initiator 2.0 microwave reactor. The product 
crystallized spontaneously as colorless needles in the pale yellow solution. The mixture was cooled to 0 °C and 
cold water (10 mL) was added into the tube. The solid was filtrated over a filter paper, washed with water (15 
mL) and hexane (20 mL) and dried under reduced pressure to afford 5-bromoisoindoline-1,3-dione (27) (394 mg, 
1.75 mmol, 79% yield) as a colorless solid which was used without further purification. 
 
1H NMR (400 MHz, DMSO) δ 11.4 (s, 1 H, NH), 8.04-7.99 (m, 2 H, Ar), 7.76 (d, 1 H, J = 7.7 Hz, Ar).  
 
 
 
Following a modified procedure,8 5-bromoisoindoline-1,3-dione (27) (1.50 g, 6.64 mmol, 1 equiv), palladium(II) 
chloride (118 mg, 0.664 mmol, 0.1 equiv), lithium chloride (28.0 mg, 0.660 mmol, 0.1 equiv) and vinyl acetate 
(28) (16.5 mL, 178 mmol, 27 equiv) were added in a microwave tube sealed with a microwave cap. The mixture 
was stirred for 28 hours at 80 °C, and then cooled down to room temperature. The solvent was removed under 
reduced pressure. Purification by silica gel chromatography (hexane/ethyl acetate 20/1 to 15/1) afforded 5-
bromo-2-vinylisoindoline-1,3-dione (29) (1.66 g, 6.59 mmol, 99% yield) as a yellow solid. 
 
Rf 0.47 (hexane/ethyl acetate 9/1); 
Mp 74.9-75.6 °C;  
1H NMR (400 MHz, DMSO) δ 8.11 (d, 1 H, J = 1.4 Hz, Ar), 8.07 (dd, 1 H, J = 8.0, 1.8 Hz, Ar), 7.84 (d, 1 H, J = 
7.9 Hz, Ar), 6.81 (dd, 1 H, J = 16.3, 9.8 Hz, =CH), 5.93 (d, 1 H, J = 16.3 Hz, =CH), 5.08 (d, 1 H, J = 9.8 Hz, 
=CH);  
13C NMR (101 MHz, CDCl3) δ 165.7, 165.1, 138.6, 133.3, 130.1, 129.5, 127.0, 125.0, 123.7, 105.1;  
IR 2927 (w), 2854 (w), 2361 (m), 1728 (s), 1640 (w), 1377 (s), 1303 (w), 1169 (m);  
HRMS (ESI) calcd for C1079BrH7NO2+ [M+H]+ 251.9655; found 251.9656. 
 
 
 
Following a modified procedure,5 a solution of dimethyl 2-diazomalonate (21) (0.05 g, 0.3 mmol, 1.5 equiv) in 
dichloromethane (0.4 mL) was added dropwise over 5 minutes to a solution of 5-bromo-2-vinylisoindoline-1,3-
dione (29) (0.05 g, 0.2 mmol, 1 equiv) and bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] (0.3 
mg, 0.4 µmol, 0.2 mol %) in dichloromethane (0.6 mL) at 0 °C. After stirring the resulting mixture overnight at 
room temperature, the solution was concentrated under reduced pressure. Purification by silica gel 
chromatography (hexane/ethyl acetate 75/25 to 70/30) afforded dimethyl 2-(5-bromo-1,3-dioxoisoindolin-2-
yl)cyclopropane-1,1-dicarboxylate (4c) (0.08 g, 0.2 mmol, 100%) as a colorless oil. 
 
                                                          
6 F. de Nanteuil, J. Waser, Angew. Chem. Int. Ed. 2011, 50, 12075-12079. 
7 K. Kacprzak, Synth. Commun. 2003, 33, 1499-1507. 
8 N. Baret, J.-P. Dulcere, J. Rodriguez, J.-M. Pons, R. Faure, Eur. J. Org. Chem. 2000, 2000, 1507-1516. 
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Rf 0.30 (hexane/ethyl acetate 3/1);  
Mp 114.8 – 117.5 °C;  
1H NMR (400 MHz, CDCl3) δ 7.99-7.95 (m, 1 H, Ar), 7.86 (dd, 1 H, J = 7.9, 1.6 Hz, Ar), 7.70 (d, 1 H, J = 7.9 
Hz, Ar), 3.82 (s, 3 H, Me-O), 3.70-3.64 (m, 1 H, CH-NPhth), 3.62 (s, 3 H, Me-O), 2.66 (dd, 1 H, J = 6.5, 6.5 Hz, 
CH2), 2.06-2.01 (m, 1 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 168.4, 167.0, 167.0, 166.5, 137.4, 133.1, 130.0, 129.4, 126.9, 124.9, 53.2, 53.0, 
34.9, 33.1, 19.6;  
IR 2956 (w), 2855 (w), 2361 (w), 1782 (w), 1730 (s), 1605 (w), 1439 (w), 1397 (m), 1331 (m), 1295 (w), 1223 
(m), 1134 (w);  
HRMS (ESI) calcd for C1579BrH13NO6+ [M+H]+ 381.9921; found 381.9920. 
 
Dimethyl 2-(5,6-dichloro-1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (4d) 
 
 
 
Following a modified procedure,8 Na2PdCl4 (27.0 mg, 0.0930 mmol, 2 mol%) was added to a stirred solution of 
4,5-dichlorophthalimide (30) (1.00 g, 4.63 mmol, 1.00 equiv) in vinyl acetate (28) (11.5 mL, 124 mmol, 26.8 
equiv), and the mixture was heated under reflux for 48 h. After solvent evaporation, the crude was purified by 
Biotage (SNAP Cartridge KP-Sil 25 g, 8:2 Hexane/AcOEt) to obtain5,6-dichloro-2-vinylisoindoline-1,3-dione 
(31) (1.12 g, 4.63 mmol, 46% yield) as a yellow solid. 
 
Rf 0.53 (6:4 Hexane/AcoEt). 
Mp 164.7 – 166.6 °C.  
1H NMR (400 MHz, CDCl3) δ 7.96 (s, 2 H, Ar), 6.84 (dd, 1 H, J = 16.4, 9.8 Hz, =CH), 6.09 (dd, 1 H, J = 16.4, 
0.3 Hz, =CH), 5.10 (dd, 1 H, J = 9.8, 0.3 Hz, =CH).  
13C NMR (101 MHz, CDCl3) δ 164.6, 139.7, 130.8, 125.8, 123.7, 105.6.  
IR 3065 (w), 3034 (w), 2952 (w), 1726 (s), 1392 (m), 1322 (m), 1288 (m), 1217 (m), 1194 (m), 1131 (m). 
HRMS (APPI ionization) calcd for C1035Cl2H6NO2+ [M+H]+ 241.9770; found 241.9771. 
 
 
 
Following a modified procedure,5 a solution of dimethyl 2-diazomalonate (21) (0.70 g, 4.4 mmol, 1.5 equiv) in 
dichloromethane (8.0 mL) was added dropwise over 5 minutes to a solution of 5,6-dichloro-2-vinylisoindoline-
1,3-dione (31) (72 mg, 3.0 mmol, 1 equiv) and bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] 
(4.5 mg, 5.9 µmol, 0.2 mol %) in dichloromethane (4.0 mL) at 0 °C. After stirring the resulting mixture 
overnight at room temperature, the solution was concentrated under reduced pressure. Purification by Biotage 
(SNAP cartridge KP-Sil 25 g, hexane/AcOEt 95/5 to 60/40) afforded dimethyl 2-(5,6-dichloro-1,3-
dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (4d) (0.81 g, 2.2 mmol, 74% yield) as a colorless solid. 
 
Rf 0.27 (hexane/ethyl acetate 8/2);  
Mp 145.9 – 148.1 °C;  
1H NMR (400 MHz, CDCl3) δ 7.92 (s, 2 H, Ar), 3.82 (s, 3 H, Me-O), 3.66 (dd, 1 H, J = 8.5, 6.7 Hz, CH-Phth), 
3.63 (s, 3 H, Me-O), 2.64 (dd, 1 H, J = 6.5. 6.5 Hz, CH2), 2.07-2.01 (m, 1 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 168.4, 167.1, 166.0, 139.5, 130.6, 125.7, 53.3, 53.2, 35.0, 33.1, 19.8;  
IR 3096 (w), 3033 (w), 2955 (w), 2851 (w), 1787 (m), 1725 (s), 1438 (m), 1398 (s), 1308 (m), 1222 (m), 1134 
(m);  
HRMS (ESI) calcd for C1535Cl2H12NO6+ [M+H]+ 372.0036; found 372.0022. 
 
Dimethyl 2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)cyclopropane-1,1-dicarboxylate (4e) 
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Following a modified procedure,8 maleimide (32) (1.30 g, 13.4 mmol, 1 equiv), palladium (II) chloride (0.237 g, 
1.34 mmol, 0.1 equiv), lithium chloride (57.0 mg, 1.34 mmol, 0.1 equiv) and vinyl acetate (28) (33.2 mL, 359 
mmol, 27 equiv) were added in a microwave tube sealed with a microwave cap. After stirring at 80 °C for 23 h, 
the resulting mixture was cooled down to room temperature. Purification by Biotage (SNAP cartridge KP-Sil 50 
g, hexane/AcOEt 93/7 to 40/60) afforded 1-vinyl-1H-pyrrole-2,5-dione (33) (1.74 g, 14.1 mmol, quantitative) as 
a bright yellow oil. 
 
Rf 0.54 (hexane/ethyl acetate 7/3);  
1H NMR (400 MHz, CDCl3) δ 6.74 (s, 2 H, CH-C=O), 6.67 (dd, 1 H, J = 16.4, 9.8 Hz, CH-N), 5.87 (d, 1 H, J = 
16.3 Hz, =CH2), 4.94 (d, 1 H, J = 9.8 Hz, =CH2);  
13C NMR (101 MHz, CDCl3) δ 168.7, 134.5, 123.1, 103.4;  
IR 3087 (w), 2359 (w), 2113 (w), 1716 (s), 1641 (m), 1384 (s), 1307 (w), 1221 (w), 1130 (w), 896 (w), 845 (m); 
HRMS (APPI) calcd for C6H5NO2 [M+] 123.0320; found 123.0323. 
 
 
 
Following a modified procedure,5 a solution of dimethyl 2-diazomalonate (21) (96 mg, 0.61 mmol, 1.5 equiv) in 
dichloromethane (1.0 mL) was added dropwise over 5 minutes to a solution of 1-vinyl-1H-pyrrole-2,5-dione (33) 
(50. mg, 0.41 mmol, 1 equiv) and bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] (0.7 mg, 0.9 
µmol, 0.2 mol %) in dichloromethane (2.0 mL) at 0 °C. The resulting mixture was stirred for 5 hours at room 
temperature and finally concentrated under reduced pressure. Purification by Biotage (SNAP cartridge KP-Sil 10 
g, hexane/AcOEt 95/5 to 70/30) afforded dimethyl 2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)cyclopropane-1,1-
dicarboxylate (4e) (66.9 mg, 0.264 mmol, 65% yield) as a colorless oil. 
 
Rf 0.38 (hexane/ethyl acetate 6/4);  
Mp 78.4-80.7 °C ;  
1H NMR (400 MHz, CDCl3) δ 6.67 (s, 2 H, CH-C=O), 3.79 (s, 3 H, Me-O), 3.66 (s, 3 H, Me-O), 3.56-3.51 (m, 1 
H, CH-N), 2.56 (dd, 1 H, J = 6.4, 6.5 Hz, CH2), 1.96-1.91 (m, 1 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 170.0, 168.4, 167.0, 134.1, 53.1, 53.0, 34.3, 32.9, 19.3;  
IR 2363 (w), 1727 (s), 1437 (w), 1332 (w), 1296 (w), 1220 (w), 1135 (w);  
HRMS (ESI) calcd for C11H11NNaO6+ [M+Na]+ 276.0479; found 276.0485. 
 
Dimethyl 2-(1,3-dioxo-1H-benzo[f]isoindol-2(3H)-yl)cyclopropane-1,1-dicarboxylate (4f) 
 
 
 
Following a modified procedure,7 naphtho[2,3-c]furan-1,3-dione (34) (500 mg, 2.52 mmol, 1 equiv) and 
formamide (26) (10.0 mL, 252 mmol, 100 equiv) were added in a 20 mL microwave vial and sealed with a 
microwave cap. The mixture was stirred until the product was completely dissolved. The mixture was heated 
twice at 200 °C for 30 sec with 10 sec pre-stirring, using Biotage Initiator 2.0 microwave reactor. The mixture 
was cooled to 0 °C and cold water (10 mL) was added into the tube. The solid was filtrated over a filter paper, 
washed with water (15 mL) and hexane (20 mL) and dried under reduced pressure to afford 1H-
benzo[f]isoindole-1,3(2H)-dione (35) (432 mg, 2.19 mmol, 87% yield) as a beige solid which was used without 
further purification. 
 
Rf 0.44 (Hexane/AcOEt 6/4);  
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Mp 267 °C decomp.;  
1H NMR (400 MHz, DMSO) δ 11.5 (s, 1 H, NH), 8.45 (s, 2 H, Ar), 8.26 (dd, 2 H, J = 6.1, 3.3 Hz, Ar), 7.76 (dd, 
2 H, J = 6.6, 3.3 Hz, Ar);  
13C NMR (101 MHz, DMSO) δ 168.9, 135.1, 130.2, 129.1, 128.7, 124.2;  
IR 3224 (w), 3071 (w), 2925 (w), 2852 (w), 1707 (s), 1447 (w), 1316 (m), 1113 (m), 1012 (w), 905 (w);  
HRMS (ESI) calcd for C12H7NNaO2+ [M+Na]+ 220.0369; found 220.0380. 
 
 
 
Following a modified procedure,8Error! Bookmark not defined. 1H-benzo[f]isoindole-1,3(2H)-dione (35) (1.70 g, 8.62 
mmol, 1 equiv), palladium(II) chloride (0.150 g, 0.860 mmol, 0.1 equiv), lithium chloride (0.0370 g, 0.860 
mmol, 0.1 equiv) and vinyl acetate (28) (21.4 mL, 231 mmol, 27 equiv) were added in a microwave tube sealed 
with a microwave cap. After stirring for 31 h at 80 °C, the resulting mixture was cooled down to room 
temperature. Purification by silica gel chromatography (hexane/ethyl acetate 17/1 to 10/1) afforded 2-vinyl-1H-
benzo[f]isoindole-1,3(2H)-dione (36) (1.26 g, 5.66 mmol, 66% yield) as a colorless solid. 
 
Rf 0.51 (hexane/ethyl acetate 8/2);  
Mp 201.9 – 202.8 °C;  
1H NMR (400 MHz, CDCl3) δ 8.37 (s, 2 H, Ar), 8.07 (dd, 2 H, J = 6.1, 3.4 Hz, Ar), 7.72 (dd, 2 H, J = 6.3, 3.3 
Hz, Ar), 6.97 (dd, 1 H, J = 16.4, 9.7 Hz, =CH), 6.20 (d, 1 H, J = 16.4 Hz, =CH), 5.12 (d, 1 H, J = 9.9 Hz, =CH);  
13C NMR (101 MHz, CDCl3) δ 166.4, 135.9, 130.5, 129.6, 127.3, 125.4, 124.3, 105.3;  
IR 3029 (w), 2949 (w), 1704 (s), 1379 (w), 1303 (w), 1218 (w), 1139 (m), 1012 (w), 975 (w), 882 (w);  
HRMS (ESI) calcd for C14H10NO2+ [M+H]+ 224.0706; found 224.0710. 
 
 
 
Following a modified procedure,5 a solution of dimethyl 2-diazomalonate (21) (0.20 g, 1.3 mmol, 1.5 equiv) in 
dichloromethane (2.0 mL) was added dropwise over 5 minutes to a solution of 2-vinyl-1H-benzo[f]isoindole-
1,3(2H)-dione (36) (0.19 g, 0.85 mmol, 1 equiv) and bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic 
acid)] (1.3 mg, 1.7 µmol, 0.2 mol %) in dichloromethane (3.0 mL) at 0 °C. After stirring the resulting mixture 
for 26 hours at room temperature the solution was concentrated under reduced pressure. Purification by silica gel 
chromatography (hexane/ethyl acetate 8/2 to 6/4) afforded dimethyl 2-(1,3-dioxo-1H-benzo[f]isoindol-2(3H)-
yl)cyclopropane-1,1-dicarboxylate (4f) (0.28 g, 0.80 mmol, 94% yield) as a colorless solid. 
 
Rf 0.39 (hexane/ethyl acetate 6/4);  
Mp 165.6 – 167.5 °C;  
1H NMR (400 MHz, CDCl3) δ 8.34 (s, 2 H, Ar), 8.06 (dd, 2 H, J = 6.0, 3.3 Hz, Ar), 7.70 (dd, 2 H, J = 6.3, 3.3 
Hz, Ar), 3.84 (s, 3 H, Me-O), 3.77 (dd, 1 H, J = 8.5, 6.7 Hz, CH-N), 3.60 (s, 3 H, Me-O), 2.78 (dd, 1 H, J = 6.5, 
6.5 Hz, CH2), 2.08 (dd, 1 H, J = 8.5, 6.4, CH2);  
13C NMR (101 MHz, CDCl3) δ 168.7, 167.7, 167.0, 135.7, 130.4, 129.4, 127.2, 125.1, 53.2, 53.1, 35.3, 33.3, 
19.8;  
IR 3034 (w), 2955 (w), 1720 (s), 1439 (m), 1393 (m), 1332 (m), 1292 (m), 1222 (m), 1134 (m), 912 (m);  
HRMS (ESI) calcd for C19H16NO6+ [M+H]+ 354.0972; found 354.0968. 
 
Dibenzyl 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (4g) 
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Following a modified procedure,5 a solution of dibenzyl 2-diazomalonate (23) (2.0 g, 6.5 mmol, 1.10 equiv) in 
dichloromethane (12.0 mL) was added dropwise over 5 minutes to a solution of 2-vinylisoindoline-1,3-dione 
(24) (1.0 g, 5.9 mmol, 1.00 equiv) and bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] (9.0 mg, 
0.012 mmol, 0.2 mol %) in dichloromethane (10.0 mL) at 0 °C. After stirring the resulting mixture overnight at 
room temperature, the solution was concentrated under reduced pressure. Purification by Biotage (SNAP 
cartridge KP-Sil 50 g, hexane/AcOEt 90/10 to 20/80) afforded dibenzyl 2-(1,3-dioxoisoindolin-2-
yl)cyclopropane-1,1-dicarboxylate (4g) (0.91 g, 2.0 mmol, 34% yield) as a colorless oil. 
 
Rf 0.60 (hexane/ethyl acetate 6/4);  
1H NMR (400 MHz, CDCl3) δ 7.78-7.73 (m, 2 H, Phth), 7.72-7.67 (m, 2 H, Phth), 7.36-7.28 (m, 5 H, Ar), 7.20-
7.13 (m, 5 H, Ar), 5.29-5.19 (m, 2 H, CH2-Ph), 5.04-4.95 (m, 2 H, CH2-Ph), 3.73 (dd, 1 H, J = 8.5, 6.7 Hz, CH-
Phth), 2.79 (dd, 1 H, J = 6.5, 6.5 Hz, CH2), 2.02 (m, 1 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 168.1, 167.8, 166.2, 135.4, 135.1, 134.3, 131.5, 128.7, 128.4, 128.4, 128.3, 
128.1, 123.6, 67.8, 67.7, 35.3, 33.5, 19.8;9 
IR 3063 (w), 3034 (w), 2954 (w), 1722 (s), 1388 (m), 1319 (m), 1285 (m), 1215 (m), 1128 (m), 980 (w);  
HRMS (ESI) calcd for C27H21NNaO6+ [M+Na]+ 478.1261; found 478.1262. 
  
                                                          
9 One of the aromatic carbons is overlapping. 
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4. 1st screening of catalysts 
 
 
Dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (4b) (10 mg, 0.034 mmol, 1 equiv) and 
indole 5 (0.051 mmol, 1.5 equiv) were dissolved in solvent (0.20 mL) and added to the Lewis acid (3.4 µmol, 0.1 
equiv) in a sealed tube closed with a septum. The mixture was stirred at room temperature for 1 hour. The 
mixture was then filtered through a short plug of silica gel (AcOEt/hexane 1/1, deactivated with 2% NEt3, 1 mL) 
and concentrated under reduced pressure to remove volatiles. The crude was analyzed by 1H NMR. 
 
Entrya R’ LA solvent 37/38b drb 
1 1-Me Cu(OTf)2 DCM 1:19 1.2:1 
2 1-Me FeCl3/Al2O3 DCM 2:1 3.5:1 
3 1-Me Sn(OTf)2 DCM 1:1.4 6:1 
4 1-Me SnCl4/SiO2 DCM 2:1 >20:1 
5 1-Me In(OTf)3 DCM 1:1.3 3.5:1 
6 1-Me Sc(OTf)3 DCM >20:1 nd 
7 H Sc(OTf)3 DCM >20:1 nd 
8 5-Cl Sc(OTf)3 DCM 
complex 
mixture 
nd 
9 5-Cl Sc(OTf)3 MeNO2 1:0.6c nd 
aReaction conditions (unless specified otherwise): 4b (0.034 mmol), indole 
(0.051 mmol), cat. (3.4 µmol), solvent (0.2 mL), rt, 1 h. bDetermined by 1H 
NMR of the crude reaction mixture. cThe cyclized product was not isolated. 
The NMR ratio was determined by analogy with the cyclized product 38. 
 
 
Dimethyl 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1-methyl-1H-indol-3-yl)ethyl)malonate (37) 
 
 
 
Rf 0.40 (Hexane/AcOEt 6/4);  
1H NMR (400 MHz, CDCl3) δ 7.82-7.77 (m, 2 H, Phth), 7.75-7.71 (m, 1 H, ArH), 7.71-7.65 (m, 2 H, Phth), 7.41 
(s, 1 H, ArH), 7.32-7.27 (m, 1 H, ArH), 7.26-7.19 (m, 1 H, ArH), 7.16-7.09 (m, 1 H, ArH), 5.79 (dd, 1 H, J = 
9.7, 6.5 Hz, N-C-H), 3.80 (s, 3 H, Me), 3.76 (s, 3 H, Me), 3.68 (s, 3 H, Me), 3.53-3.47 (m, 1 H, CH), 3.30-3.20 
(m, 1 H, CH2), 3.09-3.00 (m, 1 H, CH2).  
13C NMR (101 MHz, CDCl3) δ 169.2, 169.2, 168.1, 136.5, 133.9, 131.9, 128.7, 126.9, 123.2, 121.9, 119.6, 
119.0, 111.6, 109.3, 52.8, 52.7, 49.6, 44.5, 33.0, 30.9.  
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IR 2953 (w), 2365 (w), 1753 (m), 1736 (s), 1711 (s), 1614 (w), 1543 (w), 1469 (w), 1436 (w), 1383 (m), 1355 
(w), 1329 (m), 1275 (w), 1158 (w), 913 (w), 739 (m), 728 (s);  
HRMS (ESI) calcd for C24H23N2O6+ [M+H]+ 435.1551; found 435.1548. 
 
Dimethyl-1-(1,3-dioxoisoindolin-2-yl)-4-methyl-1,3a,4,8b-tetrahydrocyclopenta[b]indole-3,3(2H)-
dicarboxylate (38) 
 
 
 
Diastereomer 1: 
 
Rf 0.50 (Hexane/AcOEt 6/4); 
1H NMR (400 MHz, CDCl3) δ 7.90-7.85 (m, 2 H, Phth), 7.78-7.72 (m, 2 H, Phth), 7.10-7.04 (m, 1 H, ArH), 
6.87-6.83 (m, 1 H, ArH), 6.59 (td, 1 H, J = 7.4, 0.9 Hz, ArH), 6.41 (d, 1 H, J = 7.9 Hz, ArH), 5.26 (dt, 1 H, J = 
11.3, 7.4 Hz, CH), 4.96 (d, 1 H, J = 11.2 Hz, CH), 4.44 (dd, 1 H, J = 11.0, 8.1 Hz, CH), 3.80 (s, 3 H, CH3), 3.58 
(s, 3 H, CH3), 2.92 (s, 3 H, CH3), 2.79 (dd, 1 H, J = 12.9, 11.3 Hz, CH2), 2.57 (dd, 1 H, J = 12.9, 7.0 Hz, CH2);  
13C NMR (101 MHz, CDCl3) δ 171.5, 170.1, 168.2, 152.0, 134.3, 131.9, 129.9, 128.5, 123.5, 123.3, 118.3, 
107.5, 74.8, 65.4, 56.9, 53.0, 52.5, 49.1, 36.2, 35.9;  
IR 2954 (w), 2257 (w), 1731 (s), 1710 (s), 1378 (m), 1256 (m), 719 (s);  
HRMS (ESI) calcd for C24H23N2O6+ [M+H]+ 435.1551; found 435.1567. 
 
Diastereomer 2: 
 
Rf 0.50 (Hexane/AcOEt 6/4);  
1H NMR (400 MHz, CDCl3) δ 7.92-7.56 (m, 4 H, Phth), 7.08-7.01 (m, 1 H, ArH), 6.52 (d, 1 H, J = 7.9 Hz, 
ArH), 6.45-6.41 (m, 1 H, ArH), 6.32 (td, 1 H, J = 7.4, 0.7 Hz, ArH), 4.76-4.66 (m, 1 H, CH), 4.64 (dd, 1 H, J = 
8.1, 0.8 Hz, CH), 4.27 (t, 1 H, J = 8.9 Hz, CH), 3.98 (t, 1 H, J = 13.4 Hz, CH2), 3.84 (s, 3 H, CH3), 3.83 (s, 3 H, 
CH3), 2.76 (s, 3 H, CH3), 2.34 (dd, 1 H, J = 13.0, 6.4 Hz, CH2); 
13C NMR (101 MHz, CDCl3) δ 171.2, 168.8, 155.4, 134.3 (br), 128.9, 127.5, 124.2, 123.3, 118.6, 109.4, 76.1, 
64.0, 53.7, 53.3, 52.7, 48.5, 38.8, 30.8;10 
IR 2955 (w), 2924 (w), 1732 (s), 1714 (s), 1375 (m), 1268 (w), 1130 (w), 719 (s);  
HRMS (ESI) calcd for C24H23N2O6+ [M+H]+ 435.1551; found 435.1533. 
 
  
                                                          
10 Some phthalimide peaks could not be resolved. 
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5. Tuning of the aminocyclopropane structure (Scheme 3). 
 
Cyclopropane, (0.034 mmol, 1 equiv) and indole (5a) (6.0 mg, 0.051 mmol, 1.5 equiv) were dissolved in 
nitromethane (0.20 mL) and added to the catalyst (3.4 µmol, 0.100 equiv) in a tube sealed with a septum. The 
mixture was stirred at room temperature for 1 hour. The mixture was then filtered through a short plug of silica 
gel (AcOEt/hexane 1/1, deactivated with 2% NEt3, 1 mL) and concentrated under reduced pressure to remove 
volatiles and the crude was analyzed by 1H NMR. 
 
Dimethyl 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1H-indol-3-yl)ethyl)malonate (6ba) 
 
 
 
Rf 0.19 (hexane/AcOEt 6/4);  
Mp 78.2 – 82.9 °C;  
1H NMR (400 MHz, CDCl3) δ 8.41 (s, 1 H, NH), 7.80-7.73 (m, 2 H, Phth), 7.71 (d, 1 H, J = 7.9 Hz, ArH), 7.68-
7.62 (m, 2 H, Phth), 7.50 (d, 1 H, J = 1.9 Hz, ArH), 7.34 (d, 1 H, J = 8.0 Hz, ArH), 7.19-7.14 (m, 1 H, ArH), 
7.13-7.08 (m, 1 H, ArH), 5.79 (dd, 1 H, J = 9.8, 6.4 Hz, PhthN-CH), 3.74 (s, 3 H, CH3), 3.65 (s, 3 H, CH3), 3.50 
(t, 1 H, J = 7.4 Hz, CH-(CO)2), 3.26 (ddd, 1 H, J = 14.2, 9.9, 6.9 Hz, CH2), 3.09-3.00 (m, 1 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 169.4, 169.3, 168.2, 135.8, 134.1, 131.8, 126.4, 124.3, 123.3, 122.5, 120.1, 
118.9, 113.2, 111.3, 53.0, 52.9, 49.7, 44.6, 30.8;  
IR 3403 (w), 2954 (w), 2865 (w), 2363 (w), 2093 (w), 1753 (m), 1733 (s), 1710 (s), 1358 (m); HRMS (ESI) 
calcd for C23H20N2NaO6+ [M+Na]+ 443.1214; found 443.1216. 
 
Dimethyl 2-(2,2-di(1H-indol-3-yl)ethyl)malonate (7a) 
 
 
 
Rf 0.54 (hexane/AcOEt 1/1);  
1H NMR (400 MHz, CDCl3)11 δ 7.97 (s, 2 H, NH), 7.63 (d, 2 H, J = 7.9 Hz, ArH), 7.36-7.32 (m, 2 H, ArH), 
7.19-7.14 (m, 2 H, ArH), 7.07-7.03 (m, 2 H, ArH), 7.02 (d, 2 H, J = 1.7 Hz, ArH), 4.55 (t, 1 H, J = 7.8 Hz, CH), 
3.67 (s, 6 H, CH3), 3.53 (t, 1 H, J = 7.4 Hz, CH), 2.85 (t, 2 H, J = 7.5 Hz, CH2);12  
13C NMR (101 MHz, CDCl3) δ 170.1, 136.7, 126.9, 122.0, 121.8, 119.7, 119.3, 118.5, 111.1, 52.5, 50.4, 34.5, 
32.3;  
IR 3414 (m), 3056 (w), 2952 (w), 2865 (w), 2360 (w), 1731 (s), 1458 (m), 1437 (m), 1342 (m), 1269 (m), 1229 
(m), 1159 (m);  
HRMS (ESI) calcd for C23H22N2NaO4+ [M+Na]+ 413.1472; found 413.1468. 
 
  
                                                          
11 Measured at 268 K. 
12 An impurity is present in approx. 5% in 1H NMR spectrum. 
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Ratios of Friedel-Crafts products 6 and side product 7a were obtained by integrating the doublet of doublet at 
5.7-5.9 ppm for 6 and the triplet at 4.55 ppm for 7a. 
For 6aa, absence of 7a was confirmed by checking the crude at 2.75 ppm. 
 
Crude 1H NMR of 6aa – 6ga 
 
Expanded crude 1H NMR of 6aa 
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6. Synthesis of indoles 
 
1-(2-((Triisopropylsilyl)oxy)ethyl)-1H-indole (5h) 
 
 
1H-indole (5a) (0.843 g, 7.20 mmol, 1.2 equiv) was dissolved in N,N-dimethylformamide (6 mL) and NaH (60% 
in mineral oil, 0.360 g, 9.00 mmol, 1.33 equiv, 1.25 equiv compared to indole) was added at rt under strong 
stirring and the reaction mixture was stirred for one hour. N,N-Dimethylformamide (18 mL) was added to 
dissolve the white precipitate and to give a greenish solution. The reaction was cooled to 0 °C and (2-
iodoethoxy)triisopropylsilane (1.97 g, 6.00 mmol, 1 equiv) was added dropwise. The reaction was stirred 
overnight and let to slowly warm up to rt. The reaction was then quenched with water (20 mL) and the reaction 
mixture was extracted with EtOAc (3 x 25 mL). The combined organic layers were washed with water (10 mL), 
brine (3x10 mL) and dried over MgSO4. The solvent was evaporated and the crude product was dried under 
vacuum with stirring. The crude NMR did not show the presence of the alkylating agent. TLC (10:1 hexanes: 
EtOAc, Rf prod.: 0.7). Purification by flash chromatography (SiO2, 1% to 10% EtOAc in hexane) gave 1-(2-
((triisopropylsilyl)oxy)ethyl)-1H-indole (5h) (1.56 g, 4.91 mmol, 82% yield) as a colorless oil. 
 
Rf: 0.65 (hexanes:EtOAc 10:1);  
1H NMR (400 MHz, CDCl3) δ 7.66 (m, 1 H, ArH), 7.38 (dd, 1 H, J = 8.2, 0.8 Hz, ArH), 7.25-7.19 (m, 2H, ArH) 
7.13 (m, 1 H, ArH), 6.52 (dd, 1 H, J = 3.1, 0.8 Hz, ArH), 4.30 (t, 2 H, J = 6.0 Hz, CH2), 4.04 (t, 2 H, J = 5.8 Hz, 
CH2), 1.17-0.85 (m, 21 H, TIPS);  
13C NMR (101 MHz, CDCl3) δ 136.1, 128.7, 128.6, 121.3, 120.9, 119.2, 109.3, 101.0, 62.8, 48.8, 17.9, 11.9;  
IR 3056 (w), 2942 (m), 2891 (m), 2865 (s), 1514 (w), 1464 (s), 1439 (w), 1400 (w), 1387 (w), 1360 (w), 1334 
(w), 1317 (m), 1250 (w), 1200 (w), 1115 (s), 1077 (m), 1013 (m), 997 (w), 923 (m), 883 (s), 819 (w);  
HRMS (ESI) calcd for C19H32NOSi+ [M+H]+ 318.2248; found 318.2236. 
 
The characterization data correspond to the reported values.13 
 
1-Methyl-2-((triisopropylsilyl)ethynyl)-1H-indole (5l) 
 
 
 
In a 10 mL round bottom-flask, 1-methyl-1H-indole (5g) (64 µl, 66 mg, 0.50 mmol, 1 equiv) and 1-
[(triisopropylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (TIPS-EBX) (0.64 g, 1.5 mmol, 3 equiv) were dissolved 
in DCM (5 mL) under air, then water was added (0.10 mL). Lastly Pd(MeCN)4(BF4)2 (4.4 mg, 10 µmol, 2%) 
was added with strong stirring. The flask was closed and the reaction mixture was stirred overnight, when it 
became brownish. The solvent was evaporated under reduced pressure. EtOAc (25 mL) was added to the crude 
product, and the solution was washed with NaOHaq (0.1 M, 25 mL), conc. NaHCO3 (2 x 25 mL) and brine (25 
mL). The organic layer was dried over MgSO4, filtered and the solvent was evaporated under reduced pressure. 
Purification by column chromatography (SiO2, hexane to hexane/DCM 90/10) gave 1-methyl-2-
((triisopropylsilyl)ethynyl)-1H-indole (5l) (102 mg, 0.33 mmol, 66%) as a pale yellow oil. 
 
Rf: 0.75 (hexanes:EtOAc 10:1);   
1H NMR (400 MHz, CDCl3) δ 7.63 (dt, 1 H, J = 8.0, 0.9 Hz, ArH), 7.33-7.28 (m, 2 H, ArH), 7.16 (q, 1 H,  J = 4 
Hz, ArH), 6.86 (s, 1 H, ArH), 3.78 (s, 3 H, Me), 1.30-1.09 (m, 21 H, TIPS);  
13C NMR (101 MHz, CDCl3) δ 137.1, 127.1, 123.1, 122.3, 121.1, 120.1, 109.4, 107.7, 98.2, 97.8, 30.6, 18.8, 
11.4; 
IR 3058 (w), 2942 (s), 2891 (m), 2864 (s), 2150 (s), 1463 (s), 1429 (w), 1383 (m), 1364 (m), 1339 (s), 1317 (m), 
1238 (m), 1170 (w), 1152 (w), 1073 (w), 1012 (m), 997 (m), 920 (m), 883 (s), 854 (m); 
HRMS (ESI) calcd. for C20H30NSi+ [M+H]+ 312.2142; found 312.2147. 
 
                                                          
13 G. L. Tolnai, S. Ganss, J. P. Brand, J. Waser,  Org. Lett. 2013, 15, 112. 
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The characterization data correspond to the reported values.13 
 
3-((Triiso-propylsilyl)ethynyl)-1H-indole (5n) 
 
 
1-[(Triisopropylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (206 mg, 0.480 mmol, 1.2 equiv) was added to a 
stirring solution of AuCl (4.6 mg, 0.020 mmol, 0.05 equiv) and N-H indole (5a) (0.400 mmol, 1.0 equiv) in Et2O 
(8 mL) under air. The reaction was sealed and stirred at room temperature for 12 h. Et2O (10 mL) was added, the 
organic layer was washed twice with 0.1 M NaOH (15 mL). The aqueous layers were combined and extracted 
with Et2O (20 mL). The organic layers were combined, washed with saturated NaHCO3 (20 mL), brine (20 mL), 
dried with MgSO4 and concentrated under reduced pressure. Purification by flash chromatography (PET/Et2O 
8/2) afforded (5n) (102 mg, 0.342 mmol, 86%) as brown solid.  
 
Rf 0.4 (PET/Et2O 7/3, UV/Anisaldehyde);  
Mp 55-58°C;  
1H NMR (CDCl3, 400MHz) δ 8.11 (br s, 1 H; NH), 7.79 (m, 1 H; ArH), 7.40 (d, J(H,H)= 2.7 Hz, 1 H; ArH), 
7.36 (m, 1 H), 7.26 (m, 2 H; ArH), 1.22 (m, 21 H; TIPS);  
13C NMR (CDCl3, 100MHz) δ 135.1, 128.9, 128.3, 123.1, 120.8, 120.1, 111.4, 100.4, 99.3, 92.19, 18.8, 11.5;  
IR ν 3407 (m), 3062 (w), 2942 (s), 2891 (m), 2864 (s), 2152 (s), 1620 (w), 1532 (w), 1457 (s), 1416 (m), 1383 
(w), 1341 (w), 1325 (m), 1239 (s), 1128 (m), 1071 (m), 996 (m), 910 (m), 883 (s), 774 (s), 742 (s), 676 (s), 658 
(s), 628 (s);  
HRMS(ESI) calcd for C19H28NSi+ [M+H]+ 298.1991, found 298.2001. 
 
The characterization data correspond to the reported values.14 
 
3-(2-((Trimethylsilyl)oxy)ethyl)-1H-indole (5o) 
 
 
 
Sodium iodide (581 mg, 3.88 mmol, 1.25 equiv), 2-(1H-indol-3-yl)ethanol (39) (500 mg, 3.10 mmol, 1 equiv), 
acetonitrile (5.00 mL) and hexane (5.00 mL) were mixed in a 25 mL flask. Triethylamine (0.537 mL, 3.88 mmol, 
1.25 equiv) followed by chlorotrimethylsilane (0.496 mL, 3.88 mmol, 1.25 equiv) were added in one portion 
with efficient stirring of the bi-phasic mixture. The mixture was then stirred for 1 hour at room temperature. The 
two immiscible layers were separated with a separatory funnel. The organic layer was filtered through a plug of 
silica gel (hexane/AcOEt 8/2, deactivated with 2% NEt3, 30 mL) and concentrated under reduced pressure to 
afford 3-(2-((trimethylsilyl)oxy)ethyl)-1H-indole (5o) (131 mg, 0.560 mmol, 18% yield) as a colorless solid. The 
product was used without further purification. 
 
Rf 0.49 (hexane/ethyl acetate 8/2);  
1H NMR (400 MHz, CDCl3) δ 7.99 (br s, 1 H, NH), 7.63 (dd, 1 H, J = 7.9, 0.6 Hz, ArH), 7.38-7.34 (m, 1 H, 
ArH), 7.23-7.18 (m, 1 H, ArH), 7.16-7.11 (m, 1 H, ArH), 7.05-7.02 (m, 1 H, ArH), 3.87 (t, 2 H, J = 7.4 Hz, 
CH2), 3.03 (td, 2 H, J = 7.7, 0.6 Hz, CH2), 0.12 (s, 9 H, TMS);  
13C NMR (101 MHz, CDCl3) δ 136.3, 127.8, 122.1, 122.0, 119.4, 119.0, 113.1, 111.2, 63.4, 29.1, -0.3;  
HRMS (APPI) calcd for C13H20NOSi+ [M+H]+ 234.1309; found 234.1300. 
 
  
                                                          
14 J. P. Brand, J. Charpentier, J. Waser, Angew. Chem., Int. Ed. 2009, 48, 9346. 
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7. Scope of the reaction 
 
7.1. General procedures for the synthesis of bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-
(1H-indol-3-yl)ethyl)malonates 
 
 
 
7.1.1.1. Method A 
 
Bis(2,2,2-trifluoroethyl) 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate 4a (0.088 g, 0.20 mmol, 1 
equiv) and the corresponding indole (0.22 mmol, 1.1 equiv) were dissolved in diethyl ether (1.2 mL) and added 
to Sc(OTf)3 (4.9 mg, 10 µmol, 5.0%) in a tube sealed with a septum. The mixture was stirred at room 
temperature until full conversion was observed by TLC (6:4 Hexane/EtOAc, Anisaldehyde). The mixture was 
then filtered over a short plug of silica gel (AcOEt/hexane 1/1, 5 mL). The crude was concentrated under 
reduced pressure to remove volatiles. Purification by Biotage (SNAP cartridge KP-Sil 10 g) afforded the desired 
product. 
 
7.1.1.2. Method B 
 
Bis(2,2,2-trifluoroethyl) 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate 4a (0.088 g, 0.20 mmol, 1 
equiv) and the corresponding indole (0.22 mmol, 1.1 equiv) were dissolved in diethyl ether (1.2 mL) and added 
to Sc(OTf)3 (4.9 mg, 10 µmol, 5.0%) in a tube sealed with a septum. The mixture was stirred at 35 °C until full 
conversion was observed by TLC (6:4 Hexane/EtOAc, Anisaldehyde). The mixture was then filtered over a short 
plug of silica gel (AcOEt/hexane 1/1, 5 mL). The crude was concentrated under reduced pressure to remove 
volatiles. Purification by Biotage (SNAP cartridge KP-Sil 10 g, hexane/AcOEt) afforded the desired product. 
 
7.1.1.3. Method C 
 
Bis(2,2,2-trifluoroethyl) 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate 4a (0.088 g, 0.20 mmol, 1 
equiv) and the corresponding indole (0.22 mmol, 1.1 equiv) were dissolved in toluene (1.2 mL) and added to 
Sc(OTf)3 (4.9 mg, 10 µmol, 5.0%) in a tube sealed with a septum. The mixture was stirred at 60 °C until full 
conversion was observed by TLC (6:4 Hexane/EtOAc, Anisaldehyde). The mixture was then filtered over a short 
plug of silica gel (AcOEt/hexane 1/1, 5 mL). The crude was concentrated under reduced pressure to remove 
volatiles. Purification by Biotage (SNAP cartridge KP-Sil) afforded the desired product. 
 
7.2. Friedel Crafts products : Indoles 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1H-indol-3-yl)ethyl)malonate (6aa) 
 
 
Following method A and starting from 1H-indole (5a) (26 mg, 0.22 mmol, 1.1 equiv), bis(2,2,2-trifluoroethyl) 2-
(2-(1,3-dioxoisoindolin-2-yl)-2-(1H-indol-3-yl)ethyl)malonate (6aa) (95 mg, 0.17 mmol, 85% yield) was 
obtained as a colorless solid  after a reaction time of 1 hour and purification by Biotage (SNAP cartridge KP-Sil 
10 g, hexane/AcOEt 98/2 to 75/25 + 1% AcOH). 
 
Larger scale procedure: 
 
Bis(2,2,2-trifluoroethyl) 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (4a) (1.40 g, 3.19 mmol, 1 
equiv) and indole (5a) (411 mg, 3.51 mmol, 1.1 equiv) were dissolved in diethyl ether (19 mL) and added to 
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Sc(OTf)3 (78.0 mg, 159 µmol, 5.0 mol%) in a one neck flask sealed with a septum under nitrogen atmosphere. 
The mixture was stirred at room temperature for 50 minutes, when full conversion was observed by TLC (6:4 
Hexane/EtOAc, Anisaldehyde). The mixture was then filtered over a short plug of silica gel (AcOEt/hexane 1/1, 
5 mL). The crude was concentrated under reduced pressure to remove volatiles. Purification by column 
chromatography (silica gel, hexane:AcOEt 95:5 to 70:30) afforded bis(2,2,2-trifluoroethyl) 2-(2-(1,3-
dioxoisoindolin-2-yl)-2-(1H-indol-3-yl)ethyl)malonate (6aa) (1.54 g, 2.77 mmol, 87% yield). 
 
Rf 0.49 (hexane/ethyl acetate 1/1);  
Mp 69.3 – 72.6 °C;  
1H NMR (400 MHz, CDCl3) δ 8.26 (s, 1 H, NH), 7.81-7.75 (m, 2 H, Phth), 7.72 (d, 1 H, J = 8.0 Hz, ArH), 7.70-
7.65 (m, 2 H, Phth), 7.52 (d, 1 H, J = 2.5 Hz, ArH), 7.37-7.33 (m, 1 H, ArH), 7.21-7.16 (m, 1 H, ArH), 7.15-7.10 
(m, 1 H, ArH), 5.81 (dd, 1 H, J = 9.4, 6.9 Hz, PhthN-CH), 4.65-4.36 (m, 4 H, CF3-CH2), 3.71-3.66 (m, 1 H, CH-
(CO)2), 3.32-3.23 (m, 1 H, CH2), 3.18-3.10 (m, 1 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 168.2, 166.7, 166.6, 135.8, 134.2, 131.8, 126.3, 124.3, 123.4, 122.7, 122.6 (q, JC-
F = 277 Hz), 122.5 (q, JC-F = 277 Hz), 120.4, 118.9, 112.8, 111.4, 61.5 (q, JC-F = 37 Hz), 61.4 (q, JC-F = 37 Hz), 
49.0, 44.3, 30.7;  
IR 3412 (w), 3061 (w), 2979 (w), 1757 (m), 1708 (s), 1381 (m), 1357 (m), 1330 (m), 1283 (s), 1166 (s), 975 
(m);  
HRMS (ESI) calcd for C25H18F6N2NaO6+ [M+Na]+ 579.0961; found 579.0964. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(5-chloro-1H-indol-3-yl)-2-(1,3-dioxoisoindolin-2-yl)ethyl)malonate (6ab) 
 
 
 
Following method A and starting from 5-chloro-1H-indole (5b) (33 mg, 0.22 mmol, 1.1 equiv), bis(2,2,2-
trifluoroethyl) 2-(2-(5-chloro-1H-indol-3-yl)-2-(1,3-dioxoisoindolin-2-yl)ethyl)malonate (6ab) (97 mg, 0.16 
mmol, 82% yield) was obtained as a colorless solid after a reaction time of 1.5 hours and purification by Biotage 
(SNAP cartridge KP-Sil 10 g, hexane/AcOEt 98/2 to 75/25 + 1% AcOH). 
 
Rf 0.40 (hexane/ethyl acetate 6/4);  
Mp 98.7 – 102.0 °C;  
1H NMR (400 MHz, CDCl3) δ 8.29 (s, 1 H, NH), 7.83-7.78 (m, 2 H, Phth), 7.72-7.67 (m, 2 H, Phth), 7.67 (d, 1 
H, J = 2.0 Hz, ArH), 7.55 (d, 1 H, J = 2.6 Hz, ArH), 7.26 (dd, 1 H, J = 8.7, 0.4 Hz, ArH), 7.14 (dd, 1 H, J = 8.5, 
1.9 Hz, ArH), 5.72 (dd, 1 H, J = 9.6, 6.7 Hz, PhthN-CH), 4.66-4.37 (m, 4 H, CF3-CH2), 3.67-3.62 (m, 1 H, CH-
(CO)2), 3.30-3.21 (m, 1 H, CH2), 3.12-3.03 (m, 1 H, CH2);12  
13C NMR (101 MHz, CDCl3) δ 168.1, 166.6, 166.5, 134.4, 134.1, 131.8, 127.4, 126.3, 125.7, 123.6, 123.2, 
122.6 (q, JC-F = 277 Hz), 122.5 (q, JC-F = 277 Hz), 118.4, 112.7, 112.4, 61.6 (q, J = 37 Hz), 61.4 (q, J = 37 Hz), 
48.9, 44.0, 30.7;  
IR 3419 (w), 1757 (m), 1709 (s), 1464 (w), 1384 (m), 1286 (s), 1170 (s), 973 (w), 724 (m);  
HRMS (ESI) calcd for C2535ClF6H18N2O6+ [M+H]+ 591.0752; found 591.0761. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(5-methoxy-1H-indol-3-yl)-2-(1,3-dioxoisoindolin-2-yl)ethyl)malonate (6ac) 
 
 
 
Following method A and starting from 5-methoxy-1H-indole (5c) (32 mg, 0.22 mmol, 1.1 equiv), bis(2,2,2-
trifluoroethyl) 2-(2-(5-methoxy-1H-indol-3-yl)-2-(1,3-dioxoisoindolin-2-yl)ethyl)malonate (6ac) (79 mg, 0.14 
mmol, 68% yield) was obtained as a colorless solid after a reaction time of 0.5 hour and purification by Biotage 
(SNAP cartridge KP-Sil 10 g, hexane/AcOEt 97/3 to 75/25 + 1% AcOH). 
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Rf 0.41 (hexane/ethyl acetate 6/4);  
Mp 92.6 – 96.8 °C;  
1H NMR (400 MHz, CDCl3) δ 8.17 (s, 1 H, NH), 7.81-7.76 (m, 2 H, Phth), 7.70-7.65 (m, 2 H, Phth), 7.48 (d, 1 
H, J = 2.6 Hz, ArH), 7.23 (d, 1 H, J = 8.8 Hz, ArH), 7.18 (d, 1 H, J = 2.4 Hz, ArH), 6.84 (dd, 1 H, J = 8.8, 2.4 
Hz, ArH), 5.76 (dd, 1 H, J = 9.4, 6.9 Hz, PhthN-CH), 4.65-4.38 (m, 4 H, CF3-CH2), 3.84 (s, 3 H, OMe), 3.71-
3.66 (m, 1 H, CH-(CO)2), 3.31-3.23 (m, 1 H, CH2), 3.17-3.09 (m, 1 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 168.2, 166.7, 166.6, 154.6, 134.3, 131.8, 130.8, 126.8, 124.9, 123.4, 122.6 (q, JC-
F = 277 Hz), 122.5 (q, JC-F = 277 Hz), 113.2, 112.6, 112.1, 100.4, 61.5 (q, JC-F = 37 Hz), 61.4 (q, JC-F = 37 Hz), 
55.9, 49.0, 44.4, 30.6;  
IR 3414 (w), 2949 (w), 2840 (w), 1758 (m), 1708 (s), 1490 (w), 1284 (s), 1170 (s), 975 (m), 721 (m);  
HRMS (ESI) calcd for C26F6H21N2O7+ [M+H]+ 587.1247; found 587.1252. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
1H-indol-3-yl)ethyl)malonate (6ad) 
 
 
 
Following method A and starting from 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole (5d) (54 mg, 
0.22 mmol, 1.1 equiv), bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(5-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)-1H-indol-3-yl)ethyl)malonate (6ad) (86 mg, 0.13 mmol, 63% yield) was obtained as an 
colorless solid after a reaction time of 1 hour and purification by Biotage (SNAP cartridge KP-Sil 10 g, 
hexane/AcOEt 97/3 to 75/25). 
 
Rf 0.47 (hexane/ethyl acetate 6/4);  
Mp 83.6 – 87.2 °C;  
1H NMR (400 MHz, CDCl3) δ 8.31 (s, 1 H, NH), 8.16 (s, 1 H, ArH), 7.82-7.77 (m, 2 H, Phth), 7.70-7.65 (m, 2 
H, Phth), 7.63 (d, 1 H, J = 8.2 Hz, ArH), 7.57 (d, 1 H, J = 2.5 Hz, ArH), 7.34 (d, 1 H, J = 8.2 Hz, ArH), 5.89-
5.84 (m, 1 H, PhthN-CH), 4.65-4.36 (m, 4 H, CF3-CH2), 3.63 (t, 1 H, J = 7.4 Hz, CH-(CO)2), 3.24-3.06 (m, 2 H, 
CH2), 1.35 (s, 6 H, CH3), 1.35 (s, 6 H, CH3);  
13C NMR (101 MHz, CDCl3) δ 168.1, 166.7, 166.6, 137.6, 134.2, 131.9, 128.9, 126.1, 124.6, 123.5, 122.6 (q, JC-
F = 277 Hz), 122.6 (q, JC-F = 277 Hz), 120.3 (br), 113.4, 110.8, 83.7, 61.5 (q, JC-F = 37 Hz), 61.4 (q, JC-F = 37 
Hz), 49.0, 44.2, 31.6, 25.1, 24.9;  
IR 3405 (w), 2982 (w), 2934 (w), 1759 (m), 1712 (s), 1357 (s), 1286 (s), 1170 (s), 969 (w), 723 (m);  
HRMS (ESI) calcd for C31H2911BF6N2NaO8+ [M+Na]+ 705.1813; found 705.1801. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(7-bromo-1H-indol-3-yl)-2-(1,3-dioxoisoindolin-2-yl)ethyl)malonate (6ae) 
 
 
 
Following method A and starting from 7-bromo-1H-indole (5e) (43 mg, 0.22 mmol, 1.1 equiv), bis(2,2,2-
trifluoroethyl) 2-(2-(7-bromo-1H-indol-3-yl)-2-(1,3-dioxoisoindolin-2-yl)ethyl)malonate (6ae) (89 mg, 0.14 
mmol, 70% yield) was obtained as a pale yellow solid after a reaction time of 50 minutes and purification by 
Biotage (SNAP cartridge KP-Sil 25 g, hexane/AcOEt 90/10 to 45/55). 
 
Rf 0.52 (hexane/ethyl acetate 6/4);  
Mp 182.9 – 184.2 °C;  
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1H NMR (400 MHz, CDCl3) δ 8.32 (s, 1 H, NH), 7.75-7.67 (m, 2 H, Phth), 7.65-7.60 (m, 2 H, Phth), 7.58 (d, 1 
H, J = 8.0 Hz, ArH), 7.52 (d, 1 H, J = 2.4 Hz, ArH), 7.34 (d, 1 H, J = 7.6 Hz, ArH), 7.01 (t, 1 H, J = 7.8 Hz, 
ArH), 5.69 (dd, 1 H, J = 9.5, 6.8 Hz, PhthN-CH), 4.61-4.48 (m, 1 H, CF3-CH2), 4.47-4.28 (m, 3 H, CF3-CH2), 
3.62-3.55 (m, 1 H, CH-(CO)2), 3.26-3.15 (m, 1 H, CH2), 3.09-2.99 (m, 1 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 168.1, 166.63, 166.61, 134.5, 134.4, 131.8, 127.4, 125.1, 124.8, 123.5, 122.6 (q, 
JC-F = 277 Hz), 122.5 (q, JC-F = 277 Hz), 121.6, 118.2, 114.2, 105.0, 61.5 (q, JC-F = 37 Hz), 61.4 (q, JC-F = 37 
Hz), 48.9, 44.3, 30.6;12  
IR 3387 (w), 1774 (m), 1759 (m), 1712 (s), 1386 (w), 1333 (m), 1286 (m), 1173 (s);  
HRMS (ESI) calcd for C2579BrF6H18N2O6+ [M+H]+ 635.0247; found 635.0240. 
 
Dimethyl 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(6-nitro-1H-indol-3-yl)ethyl)malonate (6af) 
 
 
 
Method A was followed using 6-nitro-1H-indole (5f) (36 mg, 0.22 mmol, 1.1 equiv). The mixture was stirred at 
room temperature for 30 min and then filtered over a short plug of silica gel (AcOEt/hexane 1/1). The crude was 
concentrated under reduced pressure to remove volatiles. Potassium carbonate (2.77 mg, 0.0200 mmol, 0.100 
equiv) was added to a solution of the crude in MeOH (2.00 mL) at 0 °C. The resulting suspension was stirred for 
40 min. The mixture was then partitioned between dichloromethane (5 mL) and saturated aqueous ammonium 
chloride-brine (1:2) (5 mL). The aqueous layer was extracted two times with dichloromethane (5 mL) and the 
combined organic layers were washed with brine (5 mL) and dried over anhydrous magnesium sulfate. Volatiles 
were removed under reduced pressure. The crude was then purified by Biotage (SNAP cartridge KP-Sil 10 g, 
pentane/AcOEt 87/13 to 1/99) to afford dimethyl 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(3-(2-hydroxyethyl)-1H-
indol-2-yl)ethyl)malonate (6af) (53.7 mg, 0.115 mmol, 58% yield) as a yellow solid. 
 
Rf 0.21 (hexane/ethyl acetate 6/4);  
Mp 171.3 – 174.2 °C;  
1H NMR (400 MHz, CDCl3) δ 8.84 (s, 1 H, NH), 8.32 (d, 1 H, J = 1.9 Hz, ArH), 8.00 (dd, 1 H, J = 8.9, 2.0 Hz, 
ArH), 7.84-7.78 (m, 3 H, Phth + ArH), 7.75 (d, 1 H, J = 8.9 Hz, ArH), 7.73-7.67 (m, 2 H, Phth), 5.78 (dd, 1 H, J 
= 10.1, 6.0 Hz, PhthN-CH), 3.75 (s, 3 H, OMe), 3.65 (s, 3 H, OMe), 3.49-3.44 (m, 1 H, CH-(CO)2), 3.31-3.22 
(m, 1 H, CH2), 3.04-2.96 (m, 1 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 169.2, 169.1, 168.1, 143.8, 134.4, 134.2, 131.7, 131.0, 129.9, 123.6, 119.1, 
115.8, 114.6, 108.3, 53.1, 53.0, 49.5, 44.1, 30.7;  
IR 3367 (w), 2359 (w), 1734 (s), 1712 (s), 1513 (m), 1338 (s);  
HRMS (ESI) calcd for C23H19N3NaO8+ [M+Na]+ 488.1064; found 488.1059. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1-methyl-1H-indol-3-yl)ethyl)malonate (6ag) 
 
 
 
Following method A and starting from 1-methyl-1H-indole (5g) (29 mg, 0.22 mmol, 1.1 equiv), bis(2,2,2-
trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1-methyl-1H-indol-3-yl)ethyl)malonate (6ag) (108 mg, 0.188 
mmol, 94% yield) was obtained as a colorless solid after a reaction time of 0.5 hour and purification by Biotage 
(SNAP cartridge KP-Sil 10 g, hexane/AcOEt 97/3 to 85/15 + 1% AcOH). 
 
Larger scale procedure: 
 
Bis(2,2,2-trifluoroethyl) 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (4a) (1.25 g, 2.85 mmol, 1 
equiv) and 1-methyl-1H-indole (5g) (411 mg, 3.13 mmol, 1.1 equiv) were dissolved in diethyl ether (17 mL) and 
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added to Sc(OTf)3 (70.0 mg, 142 µmol, 5.0 mol%) in a one neck flask sealed with a septum under nitrogen 
atmosphere. The mixture was stirred at room temperature for 50 minutes, when full conversion was observed by 
TLC (6:4 Hexane/EtOAc, Anisaldehyde). The mixture was then filtered over a short plug of silica gel 
(AcOEt/hexane 1/1, 5 mL). The crude was concentrated under reduced pressure to remove volatiles. Purification 
by column chromatography (silica gel, hexane:AcOEt 95:5 to 70:30) afforded bis(2,2,2-trifluoroethyl) 2-(2-(1,3-
dioxoisoindolin-2-yl)-2-(1H-indol-3-yl)ethyl)malonate (6ag) (1.34 g, 2.35 mmol, 83% yield). 
 
Rf 0.49 (hexane/ethyl acetate 6/4);  
Mp 47.8 – 49.5 °C;  
1H NMR (400 MHz, CDCl3) δ 8.06-8.01 (m, 1 H, ArH), 7.94-7.89 (m, 1 H, ArH), 7.81-7.74 (m, 2 H, Phth), 
7.69-7.63 (m, 2 H, Phth), 7.26-7.22 (m, 1 H, ArH), 7.16-7.09 (m, 2 H, ArH), 5.80 (dd, 1 H, J = 9.3, 7.1 Hz, 
PhthN-CH), 4.65-4.37 (m, 4 H, CF3-CH2), 3.78 (s, 3 H, CH3), 3.70-3.65 (m, 1 H, CH-(CO)2), 3.30-3.21 (m, 1 H, 
CH2), 3.18-3.09 (m, 1 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 168.1, 166.7, 166.6, 136.6, 134.2, 131.9, 128.9, 126.9, 123.4, 122.6 (q, JC-F = 
277 Hz), 122.5 (q, JC-F = 277 Hz), 122.2, 119.9, 119.0, 111.1, 109.5, 61.5 (q, JC-F = 37 Hz), 61.4 (q, JC-F = 37 
Hz), 49.0, 44.3, 33.1, 30.9;  
IR 3059 (w), 2921 (w), 1758 (m), 1712 (s), 1382 (m), 1327 (m), 1284 (s), 1169 (s), 977 (m), 724 (m);  
HRMS (ESI) calcd for C26H20F6N2NaO6+ [M+Na]+ 593.1118; found 593.1136. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1-(2-((triisopropylsilyl)oxy)ethyl)-1H-indol-3-
yl)ethyl)malonate (6ah) 
 
 
 
Following method A and starting from 1-(2-((triisopropylsilyl)oxy)ethyl)-1H-indole (5h) (64 mg, 0.22 mmol, 1.1 
equiv), bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1-(2-((triisopropylsilyl)oxy)ethyl)-1H-indol-
3-yl)ethyl)malonate (6ah) (0.12 g, 0.16 mmol, 80% yield) was obtained as an colorless solid after a reaction time 
of 45 minutes and purification by Biotage (SNAP cartridge KP-Sil 10 g, hexane/AcOEt 95/5 to 78/22). 
 
Rf 0.68 (hexane/ethyl acetate 6/4);  
Mp 68.8 – 72.3 °C;  
1H NMR (400 MHz, CDCl3) δ 7.81-7.75 (m, 2 H, Phth), 7.71 (d, 1 H, J = 8.1 Hz, ArH), 7.69-7.65 (m, 2 H, 
Phth), 7.48 (s, 1 H, ArH), 7.32-7.29 (m, 1 H, ArH), 7.18 (t, 1 H, J = 7.2 Hz, ArH), 7.10 (t, 1 H, J = 7.4 Hz, ArH), 
5.78 (dd, 1 H, J = 9.8, 6.7 Hz, PhthN-CH), 4.67-4.55 (m, 1 H, CF3-CH2), 4.54-4.36 (m, 3 H, CF3-CH2), 4.30-
4.18 (m, 2 H, CH2), 3.99 (t, 2 H, J = 5.6 Hz, CH2), 3.68-3.63 (m, 1 H, CH-(CO)2), 3.34-24 (m, 1 H, CH2), 3.12-
3.03 (m, 1 H, CH2), 1.06-0.85 (m, 21 H, TIPS);  
13C NMR (101 MHz, CDCl3) δ 168.1, 166.7, 166.6, 136.1, 134.2, 131.9, 128.6, 127.0, 123.4, 122.6 (q, JC-F = 
277 Hz), 122.5 (q, JC-F = 277 Hz), 122.0, 119.8, 119.0, 111.4, 109.7, 62.7, 61.5 (q, JC-F = 37 Hz), 61.3 (q, JC-F = 
37 Hz), 49.1, 49.0, 44.4, 30.9, 17.9, 17.9, 11.9; 
IR 2946 (w), 2868 (w), 1775 (m), 1760 (m), 1714 (s), 1469 (w), 1286 (m), 1173 (s);  
HRMS (ESI) calcd for C36H42F6N2NaO7Si+ [M+Na]+ 779.2563; found 779.2548. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(6-(methoxycarbonyl)-1-methyl-1H-indol-3-
yl)ethyl)malonate (6ai) 
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Following method A and starting from methyl 1-methyl-1H-indole-6-carboxylate (5i) (38 mg, 0.22 mmol, 1.1 
equiv), bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(6-(methoxycarbonyl)-1-methyl-1H-indol-3-
yl)ethyl)malonate (6ai) (0.11 g, 0.17 mmol, 86% yield) was obtained as a colorless solid after a reaction time of 
1.5 hour and purification by Biotage (SNAP cartridge KP-Sil 10 g, hexane/AcOEt 94/6 to 68/32). 
 
Rf 0.26 (hexane/ethyl acetate 6/4);  
Mp 69.2 – 73.0 °C;  
1H NMR (400 MHz, CDCl3) δ 8.05 (d, 1 H, J = 0.6 Hz, ArH), 7.81-7.76 (m, 3 H, Phth + ArH), 7.72-7.65 (m, 3 
H, Phth + ArH), 7.55 (s, 1 H, ArH), 5.79 (dd, J = 9.5, 6.9 Hz, PhthN-CH), 4.66-4.36 (m, 4 H, CF3-CH2), 3.92 (s, 
3 H, CH3), 3.84 (s, 3 H, CH3), 3.68-3.62 (m, 1 H, CH-(CO)2), 3.31-3.21 (m, 1 H, CH2), 3.14-3.04 (m, 1 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 168.1, 168.0, 166.6, 166.5, 136.0, 134.3, 132.1, 131.7, 130.3, 123.9, 123.5, 
122.6 (q, JC-F = 277 Hz), 122.5 (q, JC-F = 277 Hz), 121.0, 118.6, 112.0, 111.7, 61.5 (q, JC-F = 37 Hz), 61.4 (q, JC-F 
= 37 Hz), 52.1, 48.9, 44.0, 33.3, 30.8;  
IR 3406 (w), 2954 (w), 2867 (w), 2094 (w), 1774 (m), 1713 (s), 1474 (w), 1439 (w), 1385 (m), 1278 (s), 1174 
(s);  
HRMS (ESI) calcd for C28F6H23N2O8+ [M+H]+ 629.1353; found 629.1347. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(2-methyl-1H-indol-3-yl)ethyl)malonate (6aj) 
 
 
 
Following method A and starting from 2-methyl-1H-indole (5j) (29 mg, 0.22 mmol, 1.1 equiv), bis(2,2,2-
trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(2-methyl-1H-indol-3-yl)ethyl)malonate (6aj) (0.11 g, 0.19 
mmol, 97% yield) was obtained as an colorless solid after a reaction time of 0.5 hour and purification by Biotage 
(SNAP cartridge KP-Sil 10 g, hexane/AcOEt 97/3 to 85/15 + 1% AcOH). 
 
Rf 0.52 (hexane/ethyl acetate 6/4);  
Mp 49.4 – 52.3 °C;  
1H NMR (400 MHz, CDCl3) δ 7.80 – 7.75 (m, 2 H, Phth), 7.72 (dt, J = 8.0, 1.0 Hz, 1 H, ArH), 7.69 – 7.64 (m, 
2H, Phth), 7.40 (s, 1 H, NH), 7.28 (dt, J = 8.3, 1.0 Hz, 1 H, ArH), 7.22 (ddd, J = 8.2, 6.9, 1.2 Hz, 1 H, ArH), 7.12 
(ddd, J = 8.0, 6.9, 1.2 Hz, 1 H, ArH), 5.80 (dd, J = 9.3, 7.1 Hz, 1 H, NCH), 4.67 – 4.53 (m, 1 H, CH2CF3), 4.53 – 
4.36 (m, 3 H, CH2CF3), 3.78 (s, 3 H, Me), 3.68 (dd, J = 7.9, 6.9 Hz, 1 H, CH), 3.26 (ddd, J = 14.0, 9.3, 6.9 Hz, 1 
H, CH2), 3.13 (ddd, J = 14.1, 8.0, 7.1 Hz, 1 H, CH2) ; 
13C NMR (101 MHz, CDCl3) δ 168.0, 166.5, 166.5, 136.5, 134.1, 131.8, 128.8, 126.7, 123.3, 122.6 (q, JC-F = 
277 Hz), 122.5 (q, JC-F = 277 Hz), 122.1, 119.8, 118.9, 111.0, 109.4, 61.5 (q, JC-F = 37 Hz), 61.4 (q, JC-F = 37 
Hz), 48.9, 44.2, 33.0, 30.7. 
IR 3396 (w), 3060 (w), 2974 (w), 2949 (w), 2872 (w), 1759 (m), 1711 (s), 1463 (w), 1356 (m), 1287 (m), 1174 
(s);  
HRMS (ESI) calcd for C26F6H21N2O6+ [M+H]+ 571.1298; found 571.1303. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(2-phenyl-1H-indol-3-yl)ethyl)malonate (6ak) 
 
 
 
Following method A and starting from 2-methyl-1H-indole (5k) (42 mg, 0.22 mmol, 1.1 equiv), bis(2,2,2-
trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(2-methyl-1H-indol-3-yl)ethyl)malonate (6ak) (118 mg, 0.187 
mmol, 93% yield) was obtained as a colorless solid  after a reaction time of 45 minutes and purification by 
Biotage (SNAP cartridge KP-Sil 10 g, hexane/AcOEt 98/2 to 70/30). 
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Rf 0.56 (hexane/ethyl acetate 6/4);  
Mp 81.6 – 84.9 °C;  
1H NMR (400 MHz, CDCl3) δ 8.18 (s, 1 H, NH), 8.14-8.10 (m, 1 H, ArH), 7.79-7.74 (m, 2 H, Phth), 7.69-7.62 
(m, 4 H, Phth + ArH), 7.52-7.43 (m, 3 H, ArH), 7.37-7.33 (m, 1 H, ArH), 7.25-7.16 (m, 2 H, ArH), 5.80-5.73 
(m, 1 H, PhthN-CH), 4.48-4.36 (m, 1 H, CF3-CH2), 4.35-4.19 (m, 3 H, CF3-CH2), 3.58-3.53 (m, 1 H, CH-(CO)2), 
3.40-3.31 (m, 1 H, CH2), 3.27-3.17 (m, 1 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 168.6, 166.6, 166.5, 138.0, 135.8, 134.2, 132.4, 131.9, 129.8, 128.9, 128.8, 
126.6, 123.4, 122.7, 122.5 (q, JC-F = 277 Hz), 121.2, 120.6, 111.0, 109.6, 61.2 (q, JC-F = 37 Hz), 61.2 (q, JC-F = 
37 Hz), 49.0, 47.1, 30.7;  
IR 3395 (w), 3063 (w), 2977 (w), 1757 (m), 1709 (s), 1454 (w), 1356 (m), 1284 (s), 1168 (s), 977 (m), 720 (m);  
HRMS (ESI) calcd for C31F6H23N2O6+ [M+H]+ 633.1455; found 633.1476. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1-methyl-2-((triisopropylsilyl)ethynyl)-1H-indol-
3-yl)ethyl)malonate (6al) 
 
 
 
Following method A and starting from 1-methyl-2-((triisopropylsilyl)ethynyl)-1H-indole (5l) (62 mg, 0.22 
mmol, 1.1 equiv), bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1-methyl-2-
((triisopropylsilyl)ethynyl)-1H-indol-3-yl)ethyl)malonate (6al) (78 mg, 0.10 mmol, 52% yield) was obtained as a 
colorless solid  after a reaction time of 1 hour and purification by Biotage (SNAP cartridge KP-Sil 10 g, 
hexane/AcOEt 95/5 to 75/25). 
 
Rf 0.56 (hexane/ethyl acetate 7/3);  
Mp 71.6 – 74.0 °C;  
1H NMR (400 MHz, CDCl3) δ 7.93 (d, 1 H, J = 8.1 Hz, ArH), 7.80-7.75 (m, 2 H, Phth), 7.68-7.63 (m, 2 H, 
Phth), 7.28-7.21 (m, 2 H, ArH), 7.17-7.12 (m, 1 H, ArH), 5.97-5.92 (m, 1 H, PhthN-CH), 4.54-4.31 (m, 4 H, 
CF3-CH2), 3.79 (s, 3 H, CH3), 3.70-3.64 (m, 1 H, CH-(CO)2), 3.54-3.45 (m, 1 H, CH2), 3.40-3.31 (m, 1 H, CH2), 
1.32-1.13 (m, 21 H, TIPS);  
13C NMR (101 MHz, CDCl3) δ 167.8, 166.6, 166.5, 137.0, 134.0, 132.0, 125.6, 123.6, 123.4, 122.7, 122.6 (q, JC-
F = 277 Hz), 122.5 (q, JC-F = 277 Hz), 120.9, 120.6, 115.5, 109.6, 103.3, 96.6, 61.3 (q, JC-F = 37 Hz), 61.3 (q, JC-F 
= 37 Hz), 49.2, 46.2, 30.8, 30.1, 18.8, 11.5;  
IR 2944 (w), 2867 (w), 2153 (w), 1776 (m), 1761 (m), 1718 (s), 1286 (m), 1173 (s);  
HRMS (ESI) calcd for C37F6H41N2O6Si+ [M+H]+ 751.2633; found 751.2633. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(3-methyl-1H-indol-2-yl)ethyl)malonate (6am) 
 
 
 
Following method B and starting from 3-methyl-1H-indole (5m) (29 mg, 0.22 mmol, 1.1 equiv), bis(2,2,2-
trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(3-methyl-1H-indol-2-yl)ethyl)malonate (6am) (94 mg, 0.16 
mmol, 82% yield) was obtained as a colorless solid after a reaction time of 1.5 hours and purification by Biotage 
(SNAP cartridge KP-Sil 10 g, hexane/ dichloromethane 80/20 to 2/98). 
 
Rf 0.50 (hexane/ethyl acetate 7/3);  
Mp 59.9 – 64.0 °C;  
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1H NMR (400 MHz, CDCl3) δ 9.08 (s, 1 H, NH), 7.88-7.83 (m, 2 H, Phth), 7.77-7.71 (m, 2 H, Phth), 7.52 (d, 1 
H, J = 7.9 Hz, ArH), 7.36 (d, 1 H, J = 8.2 Hz, ArH), 7.21 (td, 1 H, J = 7.1, 0.8 Hz, ArH), 7.13-7.08 (m, 1 H, 
ArH), 5.85 (dd, 1 H, J = 9.5, 6.5 Hz, PhthN-CH), 4.57-4.36 (m, 3 H, CF3-CH2), 4.25-4.15 (m, 1 H, CF3-CH2), 
3.49 (t, 1 H, J = 7.3 Hz, CH-(CO)2), 3.26-3.17 (m, 1 H, CH2), 2.92-2.83 (m, 1 H, CH2), 2.34 (s, 3 H, CH3);  
13C NMR (101 MHz, CDCl3) δ 168.6, 166.4, 166.2, 136.1, 134.6, 131.6, 129.5, 127.9, 123.8, 123.2, 122.5 (q, JC-
F = 277 Hz), 119.7, 119.3, 111.4, 61.5 (q, JC-F = 37 Hz), 48.6, 44.0, 31.2, 8.4;15 
IR 1773 (m), 1713 (s), 1288 (m), 1176 (s), 978 (w); 
HRMS (ESI) calcd for C26F6H21N2O6+ [M+H]+ 571.1298; found 571.1307. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(3-((triisopropylsilyl)ethynyl)-1H-indol-2-
yl)ethyl)malonate (6an) 
 
 
 
Following method C and starting from 3-((triisopropylsilyl)ethynyl)-1H-indole (5n) (66 mg, 0.22 mmol, 1.1 
equiv), bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(3-((triisopropylsilyl)ethynyl)-1H-indol-2-
yl)ethyl)malonate (6an) (71 mg, 0.097 mmol, 49% yield) was obtained as a colorless solid, after a reaction time 
of 6 hours and purification by Biotage (SNAP cartridge KP-Sil 10 g, hexane/toluene 6/4 to 9/1). 
 
Rf 0.60 (hexane/ethyl acetate 6/4);  
Mp 49.2 – 51.8 °C;  
1H NMR (400 MHz, CDCl3) δ 9.51 (s, 1 H, NH), 7.91-7.86 (m, 2 H, Phth), 7.78-7.73 (m, 2 H, Phth), 7.64 (d, 1 
H, J = 7.8 Hz, ArH), 7.40-7.36 (m, 1 H, ArH), 7.27-7.22 (m, 1 H, ArH), 7.19-7.14 (m, 1 H, ArH), 6.13-6.08 (m, 
1 H, PhthN-CH), 4.53-4.28 (m, 3 H, CF3-CH2), 3.97-3.87 (m, 1 H, CF3-CH2), 3.63 (dd, 1 H, J = 8.2, 2.3 Hz, CH-
(CO)2), 3.14 (dt, 1 H, J = 14.1, 8.8 Hz, CH2), 2.87 (ddd, 1 H, J = 13.9, 7.8, 5.9 Hz, CH2), 1.22 (s, 21 H, TIPS);  
13C NMR (101 MHz, CDCl3) δ 168.3, 166.2, 165.8, 137.1, 135.5, 134.7, 131.6, 128.1, 124.1, 123.9, 122.5 (q, JC-
F = 275 Hz), 121.1, 120.4, 111.8, 100.1, 98.3, 96.0, 61.5 (q, JC-F = 37 Hz), 61.3 (q, JC-F = 37 Hz), 48.5, 45.3, 
31.5, 18.9, 11.5;  
IR 3394 (w), 2151 (w), 1776 (m), 1716 (m), 1277 (s), 1173 (s);  
HRMS (ESI) calcd for C36F6H39N2O6Si+ [M+H]+ 737.2476; found 737.2480. 
 
Dimethyl 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(3-(2-hydroxyethyl)-1H-indol-2-yl)ethyl)malonate (6ao) 
 
 
 
Method C was followed using 3-(2-((trimethylsilyl)oxy)ethyl)-1H-indole (5o) (51 mg, 0.22 mmol, 1.1 equiv). 
The mixture was stirred at 60 °C for 25 min and then filtered over a short plug of silica gel (AcOEt/hexane 1/1). 
The crude was concentrated under reduced pressure to remove volatiles. Potassium carbonate (2.77 mg, 0.0200 
mmol, 0.100 equiv) was added to a solution of the crude in MeOH (2.00 mL) at 0 °C. The resulting suspension 
was stirred for 30 min. The mixture was then partitioned between dichloromethane (5 mL) and saturated aqueous 
ammonium chloride-brine (1:2) (5 mL). The aqueous layer was extracted two times with dichloromethane (5 
mL) and the combined organic layers were washed with brine (5 mL) and dried over anhydrous magnesium 
sulfate. Volatiles were removed under reduced pressure. The crude was then purified by Biotage (SNAP 
                                                          
15 Only one CF3 peak could be detected. 
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cartridge KP-Sil 10 g, pentane/AcOEt 85/15 to 50/50) to afford dimethyl 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(3-(2-
hydroxyethyl)-1H-indol-2-yl)ethyl)malonate (6ao) (67 mg, 0.14 mmol, 72% yield) as a pale yellow oil. 
 
Rf 0.13 (hexane/ethyl acetate 6/4); 
1H NMR (400 MHz, CDCl3) δ 9.18 (s, 1 H, NH), 7.88-7.81 (m, 2 H, Phth), 7.77-7.70 (m, 2 H, Phth), 7.56 (d, 1 
H, J = 8.0 Hz, ArH), 7.36 (d, 1 H, J = 8.1 Hz, ArH), 7.22-7.17 (m, 1 H, ArH), 7.11-7.06 (m, 1 H, ArH), 5.85 (t, 1 
H, J = 8.2 Hz, PhthN-CH), 3.90-3.85 (m, 2 H, CH2), 3.69 (s, 3 H, OMe), 3.63 (s, 3 H, OMe), 3.37 (t, 1 H, J = 7.3 
Hz, CH-(CO)2), 3.18-2.90 (m, 4 H, CH2);12  
13C NMR (101 MHz, CDCl3) δ 168.9, 168.6, 136.0, 134.5, 131.7, 131.6, 127.3, 123.7, 123.0, 119.7, 119.2, 
111.6, 111.4, 62.9, 52.9, 49.1, 44.3, 31.3, 27.9;  
IR 3550 (w), 3406 (w), 3058 (w), 2954 (w), 2884 (w), 1735 (s), 1708 (s), 1440 (m), 1385 (m), 1333 (m), 1165 
(m);  
HRMS (ESI) calcd for C25H25N2O7+ [M+H]+ 465.1656; found 465.1661. 
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7.3. Friedel Crafts products: Electron rich Aromatics 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1H-pyrrol-2-yl)ethyl)malonate (8a) 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1H-pyrrol-3-yl)ethyl)malonate (8b) 
 
  
 
Following method A and using 1H-pyrrole (0.015 mL, 0.22 mmol, 1.1 equiv), bis(2,2,2-trifluoroethyl) 2-(2-(1,3-
dioxoisoindolin-2-yl)-2-(1H-pyrrol-2-yl)ethyl)malonate (8a) (62 mg, 0.12 mmol, 61% yield) and bis(2,2,2-
trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1H-pyrrol-3-yl)ethyl)malonate (8b) (31 mg, 0.059 mmol, 30% 
yield) were obtained as colorless solids, after a reaction time of 1.5 hours and purification by Biotage (SNAP 
cartridge KP-Sil 10 g, Hex/AcOEt 96/4 to 75/25). The structures were assigned by 2D NMR experiments. 
 
Regioisomer 1: bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1H-pyrrol-2-yl)ethyl)malonate 
(8a)  
 
Rf 0.55 (hexane/ethyl acetate 6/4);  
Mp 122.2 – 123.8 °C;  
1H NMR (400 MHz, CDCl3) δ 9.28 (s, 1 H, NH), 7.86-7.80 (m, 2 H, Phth), 7.75-7.70 (m, 2 H, Phth), 6.80-6.77 
(m, 1 H, ArH), 6.21-6.17 (m, 1 H, ArH), 6.10-6.07 (m, 1 H, ArH), 5.49 (dd, 1 H, J = 9.2, 7.7 Hz, PhthN-CH), 
4.56-4.45 (m, 3 H, CF3-CH2), 4.42-4.31 (m, 1 H, CF3-CH2), 3.47 (t, 1 H, J = 7.3 Hz, CH-(CO)2), 3.04 (ddd, 1 H, 
J = 14.0, 9.2, 7.4 Hz, CH2), 2.82-2.74 (m, 1 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 168.4, 166.4, 166.3, 134.6, 131.7, 127.0, 123.7, 122.6 (q, JC-F = 277 Hz), 122.5 
(q, JC-F = 277 Hz), 119.7, 109.6, 108.0, 61.5 (q, JC-F = 37 Hz), 61.4 (q, JC-F = 37 Hz), 48.8, 46.4, 31.7;  
IR 3418 (w), 1760 (m), 1708 (s), 1386 (m), 1359 (m), 1283 (s), 1165 (s), 974 (m), 724 (m);  
HRMS (ESI) calcd for C21F6H17N2O6+ [M+H]+ 507.0985; found 507.0986. 
 
Regioisomer 2: bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1H-pyrrol-3-yl)ethyl)malonate 
(8b)  
 
Rf 0.48 (hexane/ethyl acetate 6/4);  
Mp 81.7 – 84.0 °C;  
1H NMR (400 MHz, CDCl3) δ 8.19 (s, 1 H, NH), 7.83-7.78 (m, 2 H, Phth), 7.72-7.67 (m, 2 H, Phth), 6.92-6.89 
(m, 1 H, ArH), 6.73-6.69 (q, 1 H, J = 2.6 Hz, ArH), 6.38-6.34 (m, 1 H, ArH), 5.38 (t, 1 H, J = 8.2 Hz, PhthN-
CH), 4.62-4.38 (m, 4 H, CF3-CH2), 3.58 (t, 1 H, J = 7.6 Hz, CH-(CO)2), 3.04 (t, 2 H, J = 8.1 Hz, CH2);  
13C NMR (101 MHz, CDCl3) δ 168.1, 166.7, 134.2, 132.0, 123.4, 122.6 (q, JC-F = 277 Hz), 122.6 (q, JC-F = 277 
Hz), 120.8, 118.4, 117.3, 108.5, 61.4 (q, JC-F = 37 Hz), 61.3 (q, JC-F = 37 Hz), 49.0, 46.3, 31.4; 16  
IR 3405 (w), 2359 (w), 2335 (w), 1774 (w), 1758 (w), 1712 (m), 1384 (w), 1278 (m), 1176 (m), 751 (s);  
HRMS (ESI) calcd for C21F6H17N2O6+ [M+H]+ 507.0985; found 507.0980. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1-(triisopropylsilyl)-1H-pyrrol-2-yl)ethyl) 
malonate (9a) 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1-(triisopropylsilyl)-1H-pyrrol-3-yl)ethyl) 
malonate (9b) 
 
 
 
Following method A and starting from 1-(triisopropylsilyl)-1H-pyrrole (49 mg, 0.22 mmol, 1.1 equiv), a 7:1 
mixture of two regioisomers was obtained as a colorless oil (0.12 g, 0.18 mmol, 88% yield) after a reaction time 
                                                          
16 Two carbonyls peaks are not overlapping. 
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of 25 minutes and purification by Biotage (SNAP cartridge KP-Sil 10 g, hexane/AcOEt 93/7 to 55/45). Peaks at 
5.47 and 5.36 ppm in the 1H NMR spectrum were integrated to determine the ratio of regioisomer. The structure 
of the regioisomers was assigned through 2D NMR experiments. The major isomer was isolated in pure form 
after a second purification by column chromatography for characterization. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1-(triisopropylsilyl)-1H-pyrrol-3-yl)ethyl) 
malonate (9b) 
 
Rf 0.38 (hexane/ethyl acetate 8/2);  
1H NMR (400 MHz, CDCl3) δ 7.84-7.78 (m, 2 H, Phth), 7.73-7.66 (m, 2 H, Phth), 6.83 (t, 1 H, J = 1.7 Hz, 
ArH), 6.67 (t, 1 H, J = 2.5 Hz, ArH), 6.42 (dd, 1 H, J = 2.7, 1.4 Hz, ArH), 5.36 (t, 1 H, J = 8.3 Hz, PhthN-CH), 
4.62-4.39 (m, 4 H, CF3-CH2), 3.53 (t, 1 H, J = 7.7 Hz, CH-(CO)2), 3.08-2.95 (m, 2 H, CH2), 1.41 (hept, 3 H, J = 
7.5 Hz, Si-CH), 1.07 (d, 9 H, J = 2.8 Hz, CH3), 1.05 (d, 9 H, J = 2.8 Hz, CH3);  
13C NMR (101 MHz, CDCl3) δ 168.1, 166.7, 134.1, 132.0, 124.8, 123.6, 123.4, 122.9 (q, JC-F = 277 Hz), 122.9 
(q, JC-F = 277 Hz), 122.4, 110.4, 61.4 (q, JC-F = 37 Hz), 61.3 (q, JC-F = 37 Hz), 49.0, 46.4, 31.5, 17.9, 11.7;16 
IR 2951 (w), 2869 (w), 1775 (m), 1760 (m), 1715 (s), 1287 (m), 1173 (s);  
HRMS (ESI) calcd for C30F6H37N2O6Si+ [M+H]+ 663.2320; found 663.2317. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(2-methoxyphenyl)ethyl)malonate (10a) 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(4-methoxyphenyl)ethyl)malonate (10b) 
 
 
 
Following method A and starting from anisole (0.024 mL, 0.22 mmol, 1.1 equiv), an inseparable mixture of 
bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(2-methoxyphenyl)ethyl)malonate (10a) and bis(2,2,2-
trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(4-methoxyphenyl)ethyl)malonate (10b) (66 mg, 0.12 mmol, 
60% yield) was obtained as a colorless solid after a reaction time of 45 minutes and purification by Biotage 
(SNAP cartridge KP-Sil 10 g, Hex/AcOEt 93/7 to 70/30). The integration of the peaks at 5.81 and 5.33 ppm in 
the 1H NMR spectrum were used to determine the ratio of regioisomers. 
 
Rf 0.60 (hexane/ethyl acetate 6/4);  
1H NMR (400 MHz, CDCl3) δ 7.83-7.78 (m, 4 H, Phth, Isomer 1 & 2), 7.73-7.68 (m, 4 H, Phth, Isomer 1 & 2), 
7.62 (dd, 1 H, J = 7.7, 1.3 Hz, ArH, Isomer 1), 7.47 (d, 2 H, J = 8.7 Hz, ArH, Isomer 2), 7.30-7.25 (m, 1 H, ArH, 
Isomer 1), 6.97 (dt, 1 H, J = 7.5, 0.9 Hz, ArH, Isomer 1), 6.88-6.82 (m, 3 H, ArH, Isomer 1 & 2), 5.81 (dd, 1 H, J 
= 10.1, 5.9 Hz, PhthN-CH, Isomer 1), 5.33 (dd, 1 H, J = 9.7, 7.0 Hz, PhthN-CH, Isomer 2), 4.66-4.54 (m, 2 H, 
CF3-CH2, Isomer 1 & 2), 4.53-4.35 (m, 6 H, CF3-CH2, Isomer 1 & 2), 3.78 (s, 3 H, OMe), 3.77 (s, 3 H, OMe), 
3.63 (dd, 1 H, J = 8.5, 6.3 Hz, CH-(CO)2, Isomer 1), 3.55 (dd, 1 H, J = 8.5, 6.8 Hz, CH-(CO)2, Isomer 2), 3.26-
3.13 (m, 2 H, CH2, Isomer 1 & 2), 3.07-2.98 (m, 1 H, CH2, Isomer 2), 2.97-2.89 (m, 1 H, CH2, Isomer 1);  
13C NMR (101 MHz, CDCl3) δ 168.2, 168.2, 166.7, 166.6, 166.5, 159.7, 156.9, 134.3, 134.2, 131.8, 131.8, 
130.0, 129.6, 128.6, 126.0, 123.6, 123.5, 122.7 (q, JC-F = 277 Hz), 122.6 (q, JC-F = 277 Hz), 122.6 (q, JC-F = 277 
Hz), 120.6, 114.3, 110.8, 61.5 (q, JC-F = 37 Hz), 61.4 (q, JC-F = 37 Hz), 55.7, 55.4, 52.0, 48.9, 46.3, 30.3, 30.1;17 
IR 2937 (w), 2846 (w), 1761 (m), 1715 (s), 1361 (m), 1286 (s), 1172 (s);  
HRMS (ESI) calcd for C24F6H20NO7+ [M+H]+ 548.1138; found 548.1119. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(2-hydroxyphenyl)ethyl)malonate (11a) 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-phenoxyethyl)malonate (11b) 
 
                                                          
17 Not all carbons could be resolved. 
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Following method A and starting from phenol (21 mg, 0.22 mmol, 1.1 equiv), bis(2,2,2-trifluoroethyl) 2-(2-(1,3-
dioxoisoindolin-2-yl)-2-(2-hydroxyphenyl)ethyl)malonate (11a) (13mg, 0.024 mmol, 12% yield) and bis(2,2,2-
trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-phenoxyethyl)malonate (11b) (79 mg, 0.15 mmol, 74% yield) 
were obtained as colorless solids after a reaction time of 40 minutes and purification by Biotage (SNAP cartridge 
KP-Sil 10 g, Hex/AcOEt 95/5 to 70/30). 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(2-hydroxyphenyl)ethyl)malonate (11a)  
 
Rf 0.46 (hexane/ethyl acetate 6/4);  
Mp 103.5 – 106.0 °C; 
1H NMR (400 MHz, CDCl3) δ 7.86-7.81 (m, 2 H, Phth), 7.76-7.70 (m, 2 H, Phth), 7.52 (d, 1 H, J = 7.7 Hz, 
ArH), 7.22 (t, 1 H, J = 7.5 Hz, ArH), 6.94 (t, 1 H, J = 7.5 Hz. ArH), 6.89 (d, 1 H, J = 8.1 Hz, ArH), 6.76 (s, 1 H, 
OH), 5.62 (t, 1 H, J = 8.1 Hz, PhthN-CH), 4.62-4.38 (m, 4 H, CF3-CH2), 3.58 (t, 1 H, J = 7.4 Hz, CH-(CO)2), 
3.26-3.09 (m, 2 H, CH2);12  
13C NMR (101 MHz, CDCl3) δ 168.7, 166.2, 154.0, 134.5, 131.3, 130.2, 129.5, 123.6, 123.3, 122.6 (q, JC-F = 
277 Hz), 122.5 (q, JC-F = 277 Hz),121.1, 117.9, 61.5 (q, JC-F = 37 Hz), 61.4 (q, JC-F = 38 Hz), 48.6, 47.4, 29.0. 
IR 3452 (w), 3062 (w), 2932 (w), 1766 (m), 1715 (s), 1378 (m), 1287 (s), 1172 (s);  
HRMS (ESI) calcd for C23F6H18NO7+ [M+H]+ 534.0982; found 534.0989. 
 
Bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-phenoxyethyl)malonate (11b) 
 
Rf 0.63 (hexane/ethyl acetate 6/4);  
Mp 110.2 – 111.9 °C;  
1H NMR (400 MHz, CDCl3) δ 7.87-7.81 (m, 2 H, Phth), 7.76-7.70 (m, 2 H, Phth), 7.26-7.20 (m, 2 H, ArH), 
7.02-6.95 (m, 3 H, ArH), 6.32 (dd, 1 H, J = 8.6, 5.1 Hz, PhthN-CH), 4.65-4.43 (m, 4 H, CF3-CH2), 3.99-3.94 (m, 
1 H, CH-(CO)2), 3.43-3.33 (m, 1 H, CH2), 2.80-2.71 (m, 1 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 167.1, 166.4, 155.5, 134.7, 131.4, 129.9, 124.0, 123.2, 122.6 (q, JC-F = 277 Hz), 
122.5 (q, JC-F = 277 Hz), 116.8, 76.6, 61.5 (q, JC-F = 37 Hz), 61.5 (q, JC-F = 37 Hz), 47.7, 31.6;16 
IR 3068 (w), 2940 (w), 1765 (m), 1723 (s), 1361 (m), 1289 (s), 1174 (s);  
HRMS (ESI) calcd for C23H17F6NNaO7+ [M+Na]+ 556.0801; found 556.0804. 
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8. Product modifications. 
 
Methyl 5-(1H-indol-3-yl)-2-oxopyrrolidine-3-carboxylate (12 a) 
 
 
 
To a solution of bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1H-indol-3-yl)ethyl)malonate (6aa) 
(556 mg, 1.00 mmol, 1 equiv) in MeOH (10.0 mL) was added potassium carbonate (13.8 mg, 0.100 mmol, 0.1 
equiv) at 0 °C. The resulting suspension was stirred for 30 minutes and was partitioned between 
dichloromethane (20 mL) and saturated aqueous ammonium chloride-brine (1:2) (20 mL). The aqueous layer 
was extracted with dichloromethane (20 mL) twice and the combined organic layers were dried over anhydrous 
magnesium sulfate. The solvent was removed under reduced pressure to afford the crude as a yellow solid, which 
was purified by Biotage (SNAP cartridge KP-Sil 25 g, pentane/AcOEt 85/15 to 60/40) to afford dimethyl 2-(2-
(1,3-dioxoisoindolin-2-yl)-2-(1H-indol-3-yl)ethyl)malonate (41) (302 mg, 0.717 mmol, 72% yield) as an 
colorless solid. 
 
Rf 0.19 (hexane/AcOEt 6/4);  
Mp 78.2 – 82.9 °C;  
1H NMR (400 MHz, CDCl3) δ 8.41 (s, 1 H, NH), 7.80-7.73 (m, 2 H, Phth), 7.71 (d, 1 H, J = 7.9 Hz, ArH), 7.68-
7.62 (m, 2 H, Phth), 7.50 (d, 1 H, J = 1.9 Hz, ArH), 7.34 (d, 1 H, J = 8.0 Hz, ArH), 7.19-7.14 (m, 1 H, ArH), 
7.13-7.08 (m, 1 H, ArH), 5.79 (dd, 1 H, J = 9.8, 6.4 Hz, PhthN-CH), 3.74 (s, 3 H, CH3), 3.65 (s, 3 H, CH3), 3.50 
(t, 1 H, J = 7.4 Hz, CH-(CO)2), 3.26 (ddd, 1 H, J = 14.2, 9.9, 6.9 Hz, CH2), 3.09-3.00 (m, 1 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 169.4, 169.3, 168.2, 135.8, 134.1, 131.8, 126.4, 124.3, 123.3, 122.5, 120.1, 
118.9, 113.2, 111.3, 53.0, 52.9, 49.7, 44.6, 30.8;  
IR 3403 (w), 2954 (w), 2865 (w), 2363 (w), 2093 (w), 1753 (m), 1733 (s), 1710 (s), 1358 (m);  
HRMS (ESI) calcd for C23H20N2NaO6+ [M+Na]+ 443.1214; found 443.1216. 
 
Following a modified procedure,18 dimethyl 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1H-indol-3-yl)ethyl)malonate 
(41) (84.0 mg, 0.200 mmol, 1 equiv) was added in a tube sealed with a septum with ethane-1,2-diamine (0.0410 
mL, 1.00 mmol, 5 equiv). Isopropanol (1.30 mL) was added and the resulting mixture was stirred at 70 °C for 30 
minutes. The solution was concentrated under reduced pressure and the crude was purified by Biotage (SNAP 
cartridge KP-Sil 25 g, pentane/AcOEt 75/25 to 0/100) to afford methyl 5-(1H-indol-3-yl)-2-oxopyrrolidine-3-
carboxylate (12a) (39.1 mg, 0.151 mmol, 76% yield) as an inseparable 1:1 mixture of diastereomers as a 
colorless solid. 
 
Rf 0.40/0.32 (ethyl acetate);  
Mp 51.2 – 53.6 °C;  
1H NMR (400 MHz, CDCl3) δ 8.21-8.11 (m, 2 H, NH, Isomer 1 & 2), 7.74 (d, 1 H, J = 7.9 Hz, ArH, Isomer 2), 
7.61 (d, 1 H, J = 7.9 Hz, ArH, Isomer 1), 7.42 (s, 1 H, ArH), 7.40 (s, 1 H, ArH), 7.28-7.22 (m, 3 H, ArH), 7.20-
7.13 (m, 3 H, ArH), 5.97 (s, 1 H, NH, Isomer 1), 5.90 (s, 1 H, NH, Isomer 2), 5.26 (t, 1 H, J = 6.9 Hz, CH-NH, 
Isomer 1), 5.05 (t, 1 H, J = 8.0 Hz, CH-NH, Isomer 2), 3.83 (s, 3 H, CH3), 3.83 (s, 3 H, CH3), 3.69-3.60 (m, 2 H, 
CH-(CO)2, Isomer 1 & 2), 2.98-2.90 (m, 1 H, CH2, Isomer 1), 2.89-2.73 (m, 2 H, CH2, Isomer 2), 2.57-2.47 (m, 
1 H, CH2, Isomer 1);12  
13C NMR (101 MHz, CDCl3) δ 172.8, 172.6, 170.6, 137.0, 136.9, 125.2, 125.0, 122.7, 122.6, 122.3, 121.6, 
120.0, 119.9, 119.1, 118.8, 116.2, 115.3, 111.9, 111.8, 52.9, 52.8, 50.5, 50.1, 48.9, 48.1, 33.5, 33.5;17  
IR 3274 (w), 2955 (w), 2361 (w), 1738 (s), 1696 (s), 1438 (w), 1268 (w);  
HRMS (ESI) calcd for C14H15N2O3+ [M+H]+ 259.1077; found 259.1086. 
 
Methyl 5-(1-methyl-1H-indol-3-yl)-2-oxopyrrolidine-3-carboxylate (12b) 
 
 
                                                          
18 O. Kanie, S. C. Crawley, M. M. Palcic, O. Hindsgaul, Carbohydr. Res. 1993, 243, 139-164. 
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To a solution of bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1-methyl-1H-indol-3-
yl)ethyl)malonate (6ag) (570 mg, 1.00 mmol, 1 equiv) in MeOH (10.0 mL) was added potassium carbonate (13.8 
mg, 0.100 mmol, 0.1 equiv) at 0 °C. The resulting suspension was stirred for 30 minutes. Then, the mixture was 
partitioned between dichloromethane (20 mL) and saturated aqueous ammonium chloride-brine (1:2) (20 mL). 
The aqueous layer was extracted with dichloromethane (20 mL) twice and the combined organic layers were 
dried over anhydrous magnesium sulfate. The solvent was removed under reduced pressure to afford the crude as 
a yellow solid, which was purified by Biotage (SNAP cartridge KP-Sil 25 g, pentane/AcOEt 85/15 to 60/40) to 
afford dimethyl 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1-methyl-1H-indol-3-yl)ethyl)malonate (37) (299 mg, 0.688 
mmol, 69% yield) as an colorless solid. 
 
See screening in section 4 for characterization of 37. 
 
Following a modified procedure,18 dimethyl 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1-methyl-1H-indol-3-
yl)ethyl)malonate (37) (87.0 mg, 0.200 mmol, 1 equiv) was added into a tube sealed with a septum with ethane-
1,2-diamine (0.0410 mL, 1.00 mmol, 5 equiv). Isopropanol (1.30 mL) was added and the resulting mixture was 
stirred at 70 °C for 30 minutes. The solution was concentrated under reduced pressure and the crude was purified 
by Biotage (SNAP cartridge KP-Sil 25 g, pentane/AcOEt 75/25 to 0/100) to afford Methyl 5-(1-methyl-1H-
indol-3-yl)-2-oxopyrrolidine-3-carboxylate (12b) (43.7 mg, 0.160 mmol, 80% yield) as an inseparable 1:1 
mixture of diastereomers as a colorless solid. 
 
Rf 0.42/0.28 (ethyl acetate);  
Mp 189.8 – 191.2 °C;  
1H NMR (400 MHz, CDCl3) δ 7.73 (d, 1 H, J = 8.0 Hz, ArH, Isomer 2), 7.59 (d, 1 H, J = 7.9 Hz, ArH, Isomer 
1), 7.36-7.31 (m, 2 H, ArH), 7.30-7.27 (m, 2 H, ArH), 7.19-7.12 (m, 2 H, ArH), 7.09 (s, 1 H, ArH, Isomer 2), 
7.00 (s, 1 H, ArH, Isomer 1), 6.00 (br s, 1 H, NH, Isomer 1), 5.92 (br s, 1 H, NH, Isomer 2), 5.24 (t, 1 H, J = 6.9 
Hz, CH-NH, Isomer 1), 5.03 (t, 1 H, J = 7.9 Hz, CH-NH, Isomer 2), 3.83 (s, 3 H, CH3), 3.82 (s, 3 H, CH3), 3.78 
(s, 3 H, CH3), 3.77 (s, 3 H, CH3), 3.68-3.59 (m, 2 H, CH-(CO)2, Isomer 1 & 2), 2.96-2.88 (m, 1 H, CH2, Isomer 
1), 2.87-2.70 (m, 2 H, CH2, Isomer 2), 2.55-2.46 (m, 1 H, CH2, Isomer 1);  
13C NMR (101 MHz, CDCl3) δ 172.3, 172.1, 170.6, 170.5, 137.7, 137.6, 126.9, 126.2, 125.7, 125.5, 122.5, 
122.5, 119.8, 119.7, 119.3, 119.0, 114.8, 113.8, 109.9, 109.8, 53.0, 52.9, 50.4, 49.8, 48.8, 48.1, 33.9, 33.7, 
33.0;17 
IR 3235 (w), 2953 (w), 1741 (s), 1703 (s), 1475 (w), 1334 (w), 1264 (w), 1168 (w);  
HRMS (ESI) calcd for C15H16N2NaO3+ [M+Na]+ 295.1053; found 295.1059. 
 
2,2,2-Trifluoroethyl 4-(1,3-dioxoisoindolin-2-yl)-4-(1-methyl-1H-indol-3-yl)butanoate (13) 
 
 
 
Following a modified procedure,19 a mixture of bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(1-
methyl-1H-indol-3-yl)ethyl)malonate 6ag (114 mg, 0.200 mmol, 1 equiv), lithium iodide (40.2 mg, 0.300 mmol, 
1.5 equiv) and water (7.20 µl, 0.400 mmol, 2 equiv) in 2,4,6-collidine (2.00 mL) in a microwave vial sealed with 
a microwave cap was heated at 130 °C for 3 hours. After cooling down to room temperature, the mixture was 
diluted with AcOEt (5 mL), washed with 1 M HCl (5 mL) four times and sat. NaHCO3-brine (1:3) (5 mL), dried 
over MgSO4 and concentrated under reduced pressure to afford the product (13) as a pale yellow solid (90.3 mg, 
0.200 mmol, 100% yield). 
 
Rf 0.58 (hexane/AcOEt 6/4);  
Mp 54.6 – 57.0 °C;  
1H NMR (400 MHz, CDCl3) δ 7.81-7.76 (m, 2 H, Phth), 7.74 (d, 1 H, J = 8.1 Hz, ArH), 7.69-7.63 (m, 2 H, 
Phth), 7.39 (s, 1 H, ArH), 7.31-7.26 (m, 1 H, ArH), 7.22 (t, 1 H, J = 7.5 Hz, ArH), 7.15-7.09 (m, 1 H, ArH), 5.77 
(dd, 1 H, J = 9.1, 7.1 Hz, PhthN-CH), 4.52-4.38 (m, 2 H, CF3-CH2), 3.79 (s, 3 H, CH3), 2.98-2.76 (m, 2 H, CH2), 
2.63-2.49 (m, 2 H, CH2);  
13C NMR (101 MHz, CDCl3) δ 171.2, 168.3, 136.6, 134.0, 132.0, 128.8, 127.0, 123.3, 123.0 (q, JC-F = 277 Hz), 
122.0, 119.7, 119.1, 111.9, 109.4, 60.5 (q, JC-F = 37 Hz), 45.9, 33.1, 31.4, 26.9;  
                                                          
19 Y. Kaburagi, H. Tokuyama, T. Fukuyama, J. Am. Chem. Soc. 2004, 126, 10246-10247. 
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IR 3061 (w), 2941 (w), 1761 (m), 1711 (s), 1473 (w), 1384 (m), 1330 (m), 1285 (m), 1171 (s);  
HRMS (ESI) calcd for C23F3H20N2O4+ [M+H]+ 445.1370; found 445.1356. 
 
2-(10-Methyl-6-oxo-6,7,8,9-tetrahydropyrido[1,2-a]indol-9-yl)isoindoline-1,3-dione (14) 
 
 
 
A suspension of bis(2,2,2-trifluoroethyl) 2-(2-(1,3-dioxoisoindolin-2-yl)-2-(3-methyl-1H-indol-2-
yl)ethyl)malonate 6am (122 mg, 0.214 mmol, 1equiv), lithium iodide (42.9 mg, 0.321 mmol, 1.5 equiv) and 
water (7.71 µl, 0.428 mmol, 2 equiv) in 2,4,6-collidine (2.10 mL) in a microwave vial sealed with a microwave 
cap was heated at 130 °C for 18.5 hours and then at 140 °C for 5.5 hours. After cooling down to room 
temperature, the mixture was diluted with AcOEt (5 mL), washed with 1 M HCl (5 mL) four times and sat. 
NaHCO3-brine (1:3) (5 mL) twice, dried over MgSO4, and concentrated under reduced pressure to afford the 
crude as a light brown solid. The crude was purified by Biotage (SNAP cartridge KP-Sil 25 g, pentane/AcOEt 
90/10 to 61/39) to afford 2-(10-methyl-6-oxo-6,7,8,9-tetrahydropyrido[1,2-a]indol-9-yl)isoindoline-1,3-dione 14 
(53.4 mg, 0.155 mmol, 73% yield) as an colorless solid. 
 
Rf 0.40 (hexane/AcOEt 6/4);  
Mp 177.5 – 180.8 °C;  
1H NMR (400 MHz, CDCl3) δ 8.54 (d, 1 H, J = 8.2 Hz, ArH), 7.87-7.81 (m, 2 H, Phth), 7.78-7.71 (m, 2 H, 
Phth), 7.43 (d, 1 H, J = 7.7 Hz, ArH), 7.40-7.34 (m, 1 H, ArH), 7.31-7.27 (m, 1 H, ArH), 5.85 (t, 1 H, J = 4.9 
Hz, PhthN-CH), 3.12-3.01 (m, 1 H, CH2), 2.83 (dt, 1 H, J = 17.4, 5.1 Hz, CH2), 2.54-2.37 (m, 2 H, CH2),2.09 (s, 
3 H);12  
13C NMR (101 MHz, CDCl3) δ 168.5, 167.8, 134.9, 134.5, 131.6, 130.4, 129.2, 125.6, 123.9, 123.7, 118.5, 
116.8, 115.4, 42.0, 31.6, 27.3, 8.5;  
IR 3068 (w), 1773 (w), 1713 (s), 1458 (m), 1388 (m), 1366 (m), 1326 (m);  
HRMS (ESI) calcd for C21H16N2NaO3+ [M+Na]+ 367.1053; found 367.1037. 
 
 
9. Spectra of new compounds. 
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